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Abstract 
Staphylococcus pseudintermedius (S. pseudintermedius) is one of the most important 
pathogens in small animal veterinary medicine. In the dog, it is a commensal bacterium able to 
cause severe diseases (mainly dermatological), which rapidly evolve to persistent and chronic 
infections. This pathogen is also considered a public health problem due to the rapid evolution 
and spread of antibiotic-resistant clones, in particular, the worldwide dissemination of Multi-
Drug Resistant (MDR) strains and methicillin-resistant S. pseudintermedius (MRSP). 
Nowadays, its zoonotic potential is under constant investigations.  
The first chapter of the thesis centers the attention on the typing techniques used to study 
a population of S. pseudintermedius isolated from the skin of dogs and raw milk of Holstein-
Fresian dairy cattle. The aims of this study were the investigation of the genetic relatedness of 
different S. pseudintermedius strains using three molecular typing techniques; the Ribosomal 
Spacers Amplification PCR (RSA-PCR), the Random Amplification of Polymorphic DNA 
PCR (RAPD-PCR) and the Restriction Fragment Length Polymorphism PCR (RAPD-PCR). 
Moreover, the dissemination of species-specific genes coding for exfoliative toxins (siet, expA, 
and expB), enterotoxin (seCcanine) and a bicomponent leukocidin (lukS-F) was studied to 
understand the virulence of the strains.  
The study was carried out on a final population of 40 S. pseudintermedius strains 
isolated from 42 clinical cases of deep canine pyoderma and from 5 samples of raw milk from 
Holstein-Fresian dairy cattle with intramammary infection. After the microbiological 
examination and phenotypic typing, 47 S. pseudintermedius strains were collected and 
genetically analyzed. RSA-PCR revealed the presence of a unique biotype. The dendrogram 
obtained from RAPD-PCR disclosed two important results: i) the staphylococcal strains 
isolated from dogs and cows are genetically similar underlying the ability of this pathogen to 
colonize also dairy cattle; ii) the presence of a single cluster grouping all the S. 
Abstract 
 
2 
 
pseudintermedius strains. Based on the presence of a specific restriction site in the 
phosphotransacetylase (pta) gene, RFLP-PCR confirmed the presence of 40 S. 
pseudintermedius and 7 non-S. pseudintermedius strains. The sequencing unveiled the effective 
presence of one strain of S. aureus and one of E. faecalis, 5 strains of S. schleiferi and 40 of S. 
pseudintermedius. All the S. pseudintermedius isolates were positive for siet gene, while expA 
and expB were amplified by, respectively, 10% and 17,5%. Specific enterotoxin seCcanine and 
leukotoxin luk-S-F were found with a prevalence of 35% and 92,5%, respectively. Therefore, 
the combined use of molecular typing techniques and virulence factors screening allows to 
better characterize S. pseudintermedius and to understand its zoonotic potential. 
The second chapter points out the attention to the problem of antibiotic resistance. 
Frequently, in Veterinary and Human medicine too, wide-spectrum antibiotics are prescribed 
to face with bacteria-based diseases without the microbiological examination and relative 
antibiotic-resistance screening. This could lead to the selection and spread of antibiotic-resistant 
strains.  
The aim of this work was to study the antibiotic-resistance profile of a large population 
of S. pseudintermedius strains collected in two Italian veterinary teaching hospitals, the first in 
Milan (Università degli Studi di Milano) and the second in Naples (Università degli Studi di 
Napoli “Federico II”) 
One-hundred sixteen and one-hundred twenty-six strains were collected in Milan and 
Naples, respectively. A panel of 10 different antibiotic molecules was tested with the Kirby-
Bauer assay, qualitative PCR was used to describe the dissemination of mecA and tetM/K genes. 
The results showed a high rate of resistance for amoxicillin+clavulanate, clindamycin, 
tobramycin and tetracycline also confirmed by statistical significance. The prevalence of 
methicillin-resistant strains (MRSP) was 30% in Milan and18% in Naples also confirmed by 
the amplification of mecA gene. The cohort of methicillin-sensible strains in Naples (N= 103) 
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was significantly more resistant compared to that from Milan (N= 81). In relation to the MDR 
population, all the MRSP in Milan and 91% in Naples are considered resistant to three or more 
pharmaceutical categories. These results totally agree with the recent report about the 
“Surveillance of antimicrobial resistance in Europe, 2017” and could be a starting point to set 
out a clearer use and prescription of antibiotics. 
The third chapter describes quorum-sensing and biofilm. It is known that bacteria are 
able to communicate via small peptides (Gram-positive) or lipids (Gram-negative) using a 
system called quorum-sensing. This complex behavior acts in response to external stimuli (e.g. 
cell density) and controls gene expression. Biofilm is one of the products of this 
communication, defined as a complex ecosystem of bacteria (sometimes also fungi and algae) 
enclosed in a self-produced matrix and adherent to a biotic or abiotic surface. This structure is 
frequently resistant to commonly used antibiotics and causes severe and more complex re-
infections.  
The aim of the work was to describe the biofilm-forming ability of MDR and non-MDR 
S. pseudintermedius strains investigating the dissemination of virulence factors and antibiotic-
resistance genes. A panel of 22 antibiotics was used to screen the antibiotic-resistance profiles 
of 73 S. pseudintermedius strains isolated from deep canine pyoderma. The biofilm-forming 
ability was investigated using a microtiter assay. The results clearly highlight a correlation 
between antibiotic-resistance and the ability to produce biofilm. All the MDR strains (N=42) 
are biofilm producers while 27 out of 31 non-MDR strains were able to produce biofilm.  
The last chapter of the thesis focused on an alternative strategy for the treatment of 
bacterial infections caused by Gram-positive and Gram-negative bacteria. For centuries, silver 
was used for its antimicrobial properties. Recently, the nanobiotechnology research area aimed 
to synthesize small particles (less than 100 nm) of silver metal to use as an alternative to 
traditional antibiotic-based therapies. The aim of this work was to synthesize silver 
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nanoparticles using i) a Curcuma longa infusion and ii) the supernatant of E. coli. Furthermore, 
the antibacterial properties of synthesized nanoparticles were determined against 10 S. 
pseudintermedius strains and 10 Pseudomonas aeruginosa isolates by Kirby-Bauer disk 
diffusion assay and via Minimum Inhibitory Concentration (MIC). The anti-biofilm capacities 
were also investigated using an in vitro model of biofilm growth. Results showed that silver 
nanoparticles exert strong antibacterial activity compared to antibiotic alone and these 
properties are magnified when antibiotic was adjuvated with silver. Nanoparticles are also able 
to disrupt mature biofilm by directly linking to the cell wall of bacteria causing bacterial lysis. 
The use of silver nanoparticles obtained with green technology (e.g plant or organism derived 
molecules) is an eco-friendly alternative to classical antibiotic-based therapies and can be used 
to fight against both Gram-positive and Gram-negative infections. 
Canine pyoderma 
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1. Introduction 
1.1. Canine pyoderma 
Canine pyoderma is an inflammation of the skin (pyoderma= pus in the skin). It is the 
second most frequent cause of presentation to opinion in veterinary practices and frequently 
leads to the prescription of systemic antimicrobial agents (Hill et al., 2006; Hughes et al., 2012). 
Like mastitis, it is considered a disease caused by the interaction of three factors: the host 
(genetics), the pathogen and the environment. 
Despite the (relatively) high prevalence of identification, canine pyoderma is often 
misdiagnosed leading to inappropriate treatment (Loeffler and Lloyd, 2018). Taking into 
account that peculiar skin lesions and their distribution are essential parameters (secondary to 
a careful inspection of the skin) for the correct diagnosis of this disease, a classification based 
on the depth of infection allows to range and discriminate between i) surface, ii) superficial and 
iii) deep pyoderma. 
Surface pyoderma is the less understood type of pyoderma, being characterized by 
pyotraumatic dermatitis (hot spots), intertrigo (fold pyoderma, most related to some specific 
breeds [e.g. shar pei]) and the “bacterial overgrowth syndrome”. This last condition presents an 
excessive multiplication of bacteria on the skin surface and is considered a minor determinant 
in the pathogenesis of the disease, that could arise by a dominant inflammatory cause (Pin et 
al., 2006). Erythema is the only clinical sign that makes suspect this condition; cytological 
examination demonstrates large numbers of bacteria on the inflamed skin. 
Superficial pyoderma is recognized as the most frequent type of pyoderma and requires 
the invasion of the epidermis by bacteria, that infect follicles and extend to epidermal tissue via 
the follicular ostium. Papules, pustules and epidermal collarettes associated with areas of 
alopecia and varying degrees of pruritus are the most important clinical signs that characterize 
this type of pyoderma. 
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Deep pyoderma is more serious (but less common), because the bacterial infiltration 
into the dermis and the underlying blood vessels increase the risk of bacteriaemia. Typical 
lesions include: draining sinuses, fistulae, hemorrhagic crusts, nodules and varying degrees of 
erythema. Based on the presence of neutrophils and intracellular cocci, cytology of superficial 
lesions has a diagnostic sensitivity of 93% (Udenberg et al., 2014). 
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1.2. Aetiology and pathogenesis 
The aetiological origin of canine pyoderma has to be found in cutaneous bacterial 
dysbiosis. In a recent study on the skin microbiota of dogs, the number of different species 
isolated from the dorsal nose varies from a minimum of 115 up to 490, identifying a total of 17 
Phyla such as Proteobacteria, Firmicutes, Actinobacteria, Bacteroidetes and Cyanobacteria 
(Hoffmann et al., 2014). Coagulase-positive Staphylococci (CoPS) have been recognized as 
having a major role in pyoderma (Loeffler and Lloyd, 2018) and before the refinement in 
microbiological diagnostic techniques, S. intermedius was described as its main causative 
agent. Nowadays, the predominant role of the causative agent of the superficial pyoderma is 
reserved to S. pseudintermedius, but other contagious staphylococci, including S. aureus, S. 
schleiferi, and S. hycus may be involved in the pathogenesis of pyoderma even if with a low 
prevalence (1%) (Loeffler and Lloyd, 2018). Among environmental bacteria, the genus 
Pseudomonas remains the second most frequently isolated especially in auricular pinna and ear. 
Because of its peculiar metabolism, these opportunistic pathogens are able to grow even in the 
presence of a low amount of oxygen making the auricular environment the best growing area 
to colonize. 
Staphylococcus pseudintermedius belongs to the genus Staphylococcus, from the family 
of Staphylococcaceae belonging to Bacillales Order and Firmicutes Phylum. The word 
“staphylococcus” comes from the Greek: σταφυλή, staphylē, "grape" and κόκκος, kókkos, 
"granule", which means a bunch of grapes. All staphylococci are Gram-positive cocci, with a 
diameter of 0.5-1 µm, facultative anaerobes (which allows these bacteria to grow both 
aerobically or anaerobically). On blood agar plates, S. pseudintermedius grows with large, 
round, flat and typically white colonies, with total or partial hemolysis. It is a canine commensal 
and opportunistic pathogen and can be considered analogous to S. aureus in human beings. As 
being a commensal bacterium, it should not represent a clinical problem unless the skin barrier 
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is broken (due to trauma, surgery, etc.) or the animal is immunosuppressed. In these 
circumstances, S. pseudintermedius acts like a pathogen, being able to cause severe infections 
to ears, urinary tract and the surgical site. Contrary to S. aureus, the pathophysiological 
mechanisms involved in its virulence are incompletely understood (Maali et al., 2018). 
The history of S. pseudintermedius should be used as a gold standard to describe what 
the evolution in microbiological diagnostic techniques means. Until 2005, year in which 
Devriese described the new species Staphylococcus pseudintermedius (Devriese et al., 2005), 
S. intermedius, described by Hajek in 1976, has been considered the agent causing skin and soft 
tissue infections in dogs. The name “pseudintermedius” literally means false intermedius and 
reflects the close genetic relatedness (99% similar) to S. intermedius highlighting the inefficient 
discriminative power of phenotypic tests used. Only the progress in technology and the 
development of new molecular techniques allowed the differentiation of three diverse 
staphylococcal species within S. intermedius: S. intermedius, S. pseudintermedius, and S. 
delphini. The term Staphylococcus intermedius Group (SIG) refers to the three previously cited 
staphylococci (S. intermedius, S. pseudintermedius, and S. delphini) as a group (Bannoehr et 
al., 2007b; Sasaki et al., 2007a). Only the whole genome analysis and the DNA-DNA 
hybridization assay, for species delineation and species differentiation respectively, were able 
to determine that most canine isolates phenotypically identified as S. intermedius, were S. 
pseudintermedius (Bannoehr et al., 2007b; Sasaki et al., 2007a). Based on these results, the 
scientific community proposed that all canine isolates belonging to SIG should have been 
considered as S. pseudintermedius unless proven the contrary by genetic methods. The presence 
of a single restriction site for the endonuclease MboI in the gene coding for 
phosphotransacetylase (pta) in S. pseudintermedius only, allowed to elaborate a molecular 
protocol for the diagnostic identification of this pathogen (Bannoehr et al., 2009).  
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1.3. Typing of Staphylococcus pseudintermedius 
The typing and characterization of S. pseudintermedius have a primary role in the spread 
of infection and in the determination of the genetic structure of the staphylococcal population. 
A utopic typing technique should be simple, reproducible in different laboratories, highly 
discriminatory, easily available and, as much as possible, inexpensive. The typing techniques 
most frequently used in the study of genetic population of S. pseudintermedius are based on the 
genetic variability among the isolates. During the last decades, different molecular techniques 
were developed in order to better discriminate between isolates that are epidemiologically 
related to those that are not. The molecular techniques nowadays available are grouped in the 
following categories: i) enzymatic restriction, ii) DNA amplification, iii) DNA amplification 
and enzymatic restriction and iv) gene sequencing. 
In the group of enzymatic restriction, Pulsed Field Gel Electrophoresis (PFGE) was 
considered as the gold standard for S. aureus typing until the last two decades. This technique 
allows discriminating different isolates based on the enzymatic restriction of total DNA in 
agarose in which was applied a pulsed electrical field that causes the generation of different 
strain profiles; resulting in the comparison of large genomic DNA fragments. Despite the great 
potential exhibited by this technique, nowadays is considered not suitable for long-term or 
retrospective studies because point mutations change the sites recognized by enzymes that will 
lead to loss of band pattern among similar isolates from a close population (Mehndiratta et al., 
2012). Another used technique is the Restriction Fragment Length Polymorphism (RFLP) 
based on the polymorphisms in genomic fragments derived from the enzymatic restriction of 
total DNA. 
Based on the amplification of DNA, the Random Amplification of Polymorphic DNA 
(RAPD), belonging to amplification-based typing techniques, uses a combination of universal 
primers (of approximately 10 nucleotides) to amplify DNA fragments of different length that 
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will be processed through a statistical program able to identify homologous regions between 
isolates and build a dendrogram showing the percentage of identity in a root-like structure. This 
technique can be used to screen mini-hospital associated outbreaks of Methicillin-resistant S. 
aureus (MRSA) and methicillin-resistant S. pseudintermedius (MRSP) (Lin et al., 2014). 
Multiple-Locus Variable-Number Tandem-Repeat Analysis (MLVA) is a method based on the 
analysis of the variation in the number of repeats in different genes. Originally developed in 
2003 to study S. aureus within 7 different genes (sspA, spa, sdrC, sdrD, sdrE, clfA and clfB), 
this technique was soon applied to S. pseudintermedius because its discriminative power was 
similar to PFGE but more cheaper (Pei et al., 2008; Volpe Sperry et al., 2008). 
RFLP-PCR is considered an evolution of RFLP in which, the amplification of a gene is 
followed by the enzymatic restriction of the amplicons. This technique was used by Bannoehr 
to set up the first molecular diagnostic protocol for the identification of S. pseudintermedius 
(Bannoehr et al., 2009). 
Multi Locus Sequence Typing (MLST) belongs to the last group of previously cited 
typing techniques (gene sequencing). This method focuses on the variations occurring in slowly 
mutating genes with high discriminative power. It compares DNA sequences of 7 different 
housekeeping genes; generating an allelic profile in which the differences found in each gene 
were compared and assigned to a sequence type (ST) for each isolate. The first MLST used to 
type S. pseudintermedius was adapted from that of S. aureus (Bannoehr et al., 2007a), which 
targeted 4 genes (cpn60, tuf, pta, and agrD). Recently, a more robust 7 genes-based MLST was 
set up by Solyman (cpn60, tuf, pta, purA, fdh, ack, and sar) (Solyman et al., 2013). 
Staphylococcal Cassette Chromosome (SCCmec) Typing (SCCmec Typing) analyses the 
nucleotidic differences of SCCmec to epidemiologically study MRSP or MRSA clones and 
identify the common ancestor that originates clonal expansion. From 1999 (first SCCmec 
discovered) until now, eleven SCCmec types have been classified (Shore et al., 2011). The 
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typing of SCCmec can be made using three methods based on: i) enzymatic restriction, ii) PCR 
and/or Multiplex PCR and iii) Real-Time PCR (qPCR). Starting from the original work by 
Sasaki, in which SCCmec elements of S. pseudintermedius had been classified as SCCmec III, 
Descloux et al. reported two other SCCmec elements, which were named SCCmec II-III and 
VII (Sasaki et al., 2007a; Descloux et al., 2008). Finally, in 2012, Moon et al. reported SCCmec 
V as the last member of the SCCmec element of S. pseudintermedius (Moon et al., 2012). 
The studies targeting the analysis of hypervariable regions have been extensively used 
in the last years to group bacterial genomes. The agr locus is a conserved and highly 
polymorphic region in the staphylococcal genome, responsible for the control of 70 different 
genes involved in bacterial homeostasis and virulence factors (George and Muir, 2007). In 
recent studies, this region was genetically analyzed and S. pseudintermedius clones can be 
classified in following agr groups: I, II, III, IV.  
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1.4. Antibiotic-resistance 
Bacteria are, literally, the first and oldest living organisms able to colonize our planet. 
They originated almost 4 billion years ago and, through the (archeo)genetic screening of 
antibiotic biosynthetic pathways it was possible to clarify that antibiotics are, at least, hundreds 
of millions of year old; making the fight for life the most oldest war almost in progress on our 
planet (Dcosta et al., 2011; Wright and Poinar, 2012). 
The core of the great majority of therapeutic approaches against infectious diseases 
resides in the use of antibiotics. The enormous over-use of these chemicals during the past 
decades has caused the natural selection and rapid spread of antibiotic-resistant (also called 
mutants) bacteria. The natural development of antibiotic-resistance represents one of the most 
critical issues able to hazard the treatment of infectious diseases and other therapeutic-related 
procedures (Martínez, 2012). 
Also in S. pseudintermedius, the antibiotic-resistance is of great concern due to the 
continuous increase of methicillin resistance among SIG members combined with multiple 
resistance (Schwarz et al., 2008). Until 2006, S. (pseud)intermedius isolates were generally less 
resistant to penicillinase stable β-lactam antibiotics and the MRSP-related infections were 
totally under control due to their poor prevalence (van Duijkeren et al., 2011); now MRSP has 
emerged as a significant animal health problem in Veterinary Medicine and Human Medicine. 
The mecA gene, naturally present on mobile elements in the staphylococcal genome, called 
Staphylococcal Chromosome Cassette (SCCmec) is the genetic cause of methicillin resistance. 
Several studies have clarified the ability of genetic exchange of SCCmec elements between 
different staphylococcal species (Wielders et al., 2001). In the study of Robinson and Enright, 
the authors proposed that the mecA gene currently found in MRSA may have originally been 
carried by coagulase-negative staphylococci and later exchanged to S. aureus (Robinson and 
Enright, 2003). Moreover, Kadlec and Schwarz stated, in their study, the identification of most 
Antibiotic-resistance 
 
13 
 
antibiotic-resistance genes in common between S. pseudintermedius genome and other 
staphylococcal species as well as in a few other Gram-positive bacteria (Kadlec and Schwarz, 
2012). 
S. pseudintermedius, like S. aureus and S. haemolyticus, displays multi-resistance 
against tetracyclines (Schwarz et al., 1998), macrolides, lincosamides and streptogramins 
(Boerlin et al., 2001), aminoglycosides and aminocyclitols (Boerlin et al., 2001), 
fluoroquinolones (Intorre et al., 2007) and methicillin (Sasaki et al., 2007b; Zakour et al., 
2012). In the S. pseudintermedius ED99 genome, (the first strain sequenced in 2011 (Zakour et 
al., 2011)) four transposons containing one or more genes coding for antibiotic-resistance were 
identified: Tn552, Tn554-like, Tn5405 and Tn5801. Tn552 and Tn554-like encode for the bla 
operon, responsible for beta-lactam resistance, and were also found in S. aureus, S. epidermidis, 
and S. haemolyticus. Tn5405 encodes the aminoglycoside-streptothricin resistance (gene aad6-
sat4-aphA-3) and is found to be associated with the ermB gene, coding for macrolide-
lincosamide-streptogramin resistance. Tn5801 is a conjugative transposon carrying tetK gene 
and coding for tetracyclines resistance (Zakour et al., 2012). 
The colonization and infections of MRSP have been described in different animal 
species such as dogs, cats, horses, and birds with higher prevalence in dogs than in cats 
(Hanselman et al., 2009; Weese and Duijkeren, 2009; Ruscher et al., 2010). In dogs with 
pyoderma staphylococcal strains isolated on the skin as the one collected from the lesions are 
phenotypically indistinguishable and they can act as a reservoir for MRSP infections (Beck et 
al., 2012). In different studies, the prevalence of MRSP colonization was 7% in dogs with skin 
diseases and 4% in healthy cats, whereas no MRSP was found in cats with inflammatory skin 
disorders (Pin et al., 2006; Hanselman et al., 2009; Moon et al., 2012). In a recent study, 
Perreten et al. reported the resistance to 11 antibiotics by 103 epidemiologically not related 
MRSP clones isolated from a dog in Europe (Italy, Germany, France, Denmark, Sweden, 
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Switzerland, and the Netherlands) and North America (Perreten et al., 2010). From a genetical 
point of view (MLST analysis), the major clonal lineage commonly isolated in Europe is the 
ST 71 carrying the SCCmec II-III, whereas in America is the ST 68 carrying the SCCmec V 
(van Duijkeren et al., 2011). 
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1.5. Virulence factors of S. pseudintermedius 
The genome of S. pseudintermedius is composed of 2,5 Mb and an average G+C content 
of 37.6% (the average of other staphylococci is 32%). From the analysis of the chromosome, 
Zakour et al. defined that the genetic core of S. pseudintermedius is composed of 1214 genes, 
these are shared between S. aureus, S. epidermidis, S. haemolyticus, S. saprophyticus, S. 
carnosus, S. delphini, and S. intermedius (Zakour et al., 2011). The genetic core harbors 
housekeeping genes that are associated with metabolism and homeostasis. Also species-specific 
genes (e.g. surface binding proteins, adhesion factors, and exoenzymes) are classified as core 
genome because in most the cases these virulence determinants are essential for pathogenicity 
and exploitation of pivotal cellular functions. All the other genes are formerly constituent of the 
accessory genome. This class of genes is considered the most variable because frequently 
subjected to selective pressure and environmental selection that acts in terms of positive 
selection (maintenance of genetic function) or negative (loss of non-functional genetic 
determinants). Horizontal transfer genes (or plasmids), pathogenicity islands transposons and 
chromosomal cassettes are all examples of accessory genes that act in synergy with the core 
genome and can be lost or acquired by different bacteria. It is already known that SCCmec of 
S. aureus was derived from coagulase-negative staphylococci and then acquired and clonally 
shared by coagulase-positive staphylococci (Robinson and Enright, 2003). 
Bacteria live in strict connection to the host and the surrounding environment and are 
absolutely dependant on a precise modulation of virulence determinants expression 
(Dhanawade et al., 2010; Iyori et al., 2010a; Cue et al., 2012). For this reason, the evolution 
has selected well-characterized regulatory elements: i) the locus sar or staphylococcal 
accessory regulator and ii) the locus agr or accessory gene regulator. In S. pseudintermedius 
genome the following SarA proteins have been identified: sarA, sarR, and sarZ (Bannoehr et 
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al., 2011; Zakour et al., 2012; McCarthy et al., 2014). They depend on agr locus and regulate 
the synthesis of enzymes with protease activity (Ji et al., 2005; Little et al., 2019).  
Belonging to the two-component regulatory systems family, agr locus is devoted to the 
global communication system called quorum-sensing (QS) able to control over 70 different 
genes (Little et al., 2019). This locus consists of 4 genes (agrA, D, C and B) that are co-
expressed. The AgrD pro-peptide is the precursor of the autoinducing peptide (AIP) that is the 
main responsible for QS activities. After the export by AgrB, the AIP molecules are tracked by 
the intermembrane complex AgrC/AgrA. The activation of AgrA protein induces positive 
feedback on agr locus leading in the upregulation of proteases and toxins and the 
downregulation of surface proteins (Koenig et al., 2004; George and Muir, 2007; McCarthy et 
al., 2014). The presence of different types of AIP strictly define the species-specific activity 
exerted by the autoinducers; in particular, four AIP variants (RIPTSTGFF [variant I], 
RIPISTGFF [variant II], KIPTSTGFF [variant III], and KYPTSTGFF [variant IV]) are specific 
for S. pseudintermedius (Sung et al., 2006; Bannoehr et al., 2007b). 
Similar to S. aureus, S. pseudintermedius expresses a huge panel of virulence factors, 
including surface proteins (e.g. clumping factor and protein A), enzymes (e.g. coagulase, 
thermonuclease, and proteases) and toxins (e.g. cytotoxins, exfoliative toxins, and 
enterotoxins). 
The initial adherence of micro-organisms to host epithelial tissue remains the 
fundamental step without which bacteria can not infect and disseminate through the host’s 
structures. Of pivotal importance to exert this essential function are the Cell Wall Anchored 
proteins (CWA proteins) which are peptides physically connected to the underlying 
peptidoglycan layers (Iyori et al., 2010b; Crawford et al., 2016). Based on structure-function 
analysis, a classification of CWA proteins was proposed by Foster et al., creating four distinct 
groups: i) Microbial Surface Components Recognizing Adhesive Matrix Molecules 
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(MSCRAMMs), ii) Near Iron Transporter (NEAT), iii) three-helical bundle motif proteins and 
iv) G5-E repeat family (Foster et al., 2014). 
S. pseudintermedius shares with S. aureus several host binding-proteins, including those 
that link to the extracellular matrix (ECM), fibrinogen, fibronectin, and cytokeratin (Bannoehr 
et al., 2011; McCarthy et al., 2014). The genome of S. pseudintermedius contains 18 cell wall-
associated (CWA) proteins classified as Staphylococcus pseudintermedius surface proteins (Sps 
proteins, followed by the capital letter A to R). Two of them (SpsD and SpsL) have been 
demonstrated to mediate binding to host proteins (e.g. fibrinogen, fibronectin, and cytokeratin-
10) (Richards et al., 2018). In vitro studies have proven evidence about the invasive abilities of 
both SpsD and SpsL to penetrate canine progenitor epidermal keratinocytes in a fibronectin-
dependent manner (Pietrocola et al., 2013, 2015). The immunoglobulin G (Ig-G)-binding 
protein A (spA) was used as a target for molecular typing in S. aureus. In S. pseudintermedius 
two Sps proteins (SpsP and SpsQ) were found to be orthologues to spA protein (Bannoehr and 
Guardabassi, 2012; Balachandran et al., 2018). 
S. pseudintermedius is able to express different types of exoproteins including: i) 
enzymes (e.g. lipases, thermonuclease, aureolysin), ii) non-enzymatic activators (e.g. 
staphylocoagulase), and iii) exotoxins (e.g. cytolytic toxins, leukocidins, exfoliative toxins, and 
enterotoxins). 
In the first group, are encased different virulence factors important for the maintenance 
of bacteria inside the host’s tissues. Triacylglycerol lipase (lip) and lipase (geh) are considered 
the most abundant surfactant produced by bacteria, they reduce the surface tension of the 
medium in which they are secreted, avoiding the bacterial clearance exerted by amphiphilic 
molecules produced by host’s tissues (e.g. fatty acids and lipid molecules), in vitro they impair 
the function of different immune cells like macrophages or platelets (Jaeger et al., 1994). 
Following the classification proposed by Gautam and Tyagi, the major classes of biosurfactants 
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include: glycolipids, lipopeptide, lipoprotein, fatty acids, phospholipids, neutral lipids, 
polymeric biosurfactants, particulate biosurfactant (Gautam and Tyagi, 2006). 
Proteases are able to degrade a large variety of pivotal host’s proteins. One of the most 
important proteases in the Staphylococcus genus is the aureolysin, a member of the thermolysin 
family of zinc-metalloprotease. In S. aureus, this protein was shown to have a role in 
staphylococcal innate immune escape through the cleavage of peptide LL-37 (Laarman et al., 
2011). Another important family of proteases, directly linked to virulence and survival under 
stress conditions (Frees et al., 2003), is ClpP (caseinolytic protease) family. This protease is 
associated with two different ATPase proteins: ClpA or ClpX. If ClpP is not linked with 
ATPases, it can only degrade small peptides(Woo et al., 1989), but when associated with either 
ClpA or ClpX it can degrade specific substrates (Frees et al., 2003).  
The htraA gene encodes for a serine protease that was found in all the genomes of S. 
pseudintermedius analyzed by McCarthy in 2015. This exoenzyme confers the ability to adhere 
to fibronectin through the degradation of the fibronectin-binding protein.  
One of the most used tests to classify staphylococci is based on the detection of 
coagulase activity. Currently, seven species of coagulase-positive staphylococci (CoPS) have 
been identified: S. aureus, S. intermedius, S. delphini, S. pseudintermedius S. schleiferi subsp. 
coagulans, S. hyicus, and S. lutrae, (Sasaki et al., 2010). The coagulase test is based on the 
ability of this enzyme to bind to prothrombin and trigger the conversion of fibrinogen to fibrin 
(Vanassche et al., 2010). 
Exotoxins produced by S. pseudintermedius have the ability to lyse numerous cell lines 
because their molecular targets reside on the cytoplasmatic membrane. 
Among cytotoxins, S. pseudintermedius produces two of the four predicted hemolysins 
of S. aureus, α-hemolysin, and β-hemolysin and is able to cause hemolysis of rabbit 
erythrocytes and hot-cold hemolysis of sheep erythrocytes (Bannoehr and Guardabassi, 2012). 
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As happen for S. aureus, β-hemolysin has a peculiar activity against sphingomyelin 
(Dziewanowska et al., 1996) this characteristic explains why the erythrocytes of ungulates 
(naturally with a high content of sphingomyelin) are more susceptible to this cytotoxin.  
Leukocidins have to be taken into account when describing the virulence of 
staphylococcal strains. S. pseudintermedius produces a bi-component leukocidin, Luk-I. Its 
characterization and the analysis of the sequence have shown that similar to PVL, Luk-I is 
encoded by two co-transcribed genes, lukS and lukF, in the lukI operon (Keiko Futagawa-Saito 
et al., 2004). Luk-I has a specific cytotoxic activity for polymorphonuclear cells but is only 
slight hemolytic for rabbit erythrocytes (Prevost et al., 1995). 
Being the first causative agent of dermatological-related infections, the ability of S. 
pseudintermedius to produce different exfoliative toxins is not a novelty. It is known, today, 
that this pathogen is able to express three distinct exfoliative toxins: SIET, ExpA, and ExpB. 
The first that has been described, in 2006, is the Staphylococcus pseudintermedius exfoliative 
toxin (SIET) (Lautz et al., 2006). This toxin has a specific effect on epithelial cells. Through 
numerous in vitro tests, in which animal models (e.g old chickens, hamsters, and dogs) were 
exposed by subcutaneous injections to this cytotoxin, the exfoliative effect was observed 1-day 
post-inoculation (Terauchi et al., 2003b, 2003a). In particular, dogs injected with purified SIET 
shown clinical signs (e.g. erythema, exfoliation, etc) similar to symptoms seen in pyoderma 
(Bannoehr and Guardabassi, 2012). The second exfoliative toxin, originally EXI and 
subsequently ExpA, was identified in three canine isolates by PCR with primers designed for 
the amplification of exfoliative toxins of S. aureus and S. hyicus (Futagawa-Saito et al., 2009). 
The sequence homology of ExpA with exfoliative toxins of S. aureus and S. hyicus was about 
43-68%. The third and last toxin, ExpB, was discovered in 2010 (Iyori et al., 2010a). It is able 
to cause intraepithelial splitting targeting desmoglein-1 (Dsg-1) only in dogs. 
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The last family of virulence determinant analyzed are those able to cause an unnatural 
immune response and commonly known as superantigens, in particular, enterotoxins. Also, S. 
pseudintermedius is able to produce two different enterotoxins. A distinct variant of S. aureus 
SEC was the fist described, being found in dogs the new superantigen was named SECcanine 
(Edwards et al., 1997). This protein share with all the other component of the enterotoxin 
family, quite the same sequence and exactly the same function, being able to cause T- cells 
proliferation. The second enterotoxin that has been discovered was se-int in 2004 (K. Futagawa-
Saito et al., 2004). 
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1.6. Quorum-sensing and biofilm 
Biofilm was supposed to be discovered by Antoni Van Leeuwenhoek, the father of 
modern microscopy, during his studies on tooth surfaces that lead to the observation of the first 
microbial biofilms even if not knowing about its existence. In 1943 Zobell experimentally 
demonstrated that the number of bacteria adherent to a surface in seawater was substantially 
higher than in the seawater itself (Zobell, 1943). A few years later, Costerton presented a theory 
of biofilm that focused on the mechanisms by which bacteria adhere to living and non-living 
materials (Costerton, 1978). In its study, Costerton, observed that bacterial aquatic 
communities, adherent on a surface, were encased in a glycocalyx matrix that was shown to 
mediate adhesion, suggesting that biofilm formation could be assumed as an evolutionary 
mechanism that allows bacteria also to survive in competitive environments, supporting the 
selection of pathogens protected from the external ecosystem (Costerton, 1978). 
The most complete and accepted definition of biofilm was given by Donald and 
Casterton and assume that “[biofilm] is a microbially derived sessile community characterized 
by cells that are irreversibly attached to a substratum or interface or to each other, are 
embedded in a matrix of extracellular polymeric substances that they have produced, and 
exhibit an altered phenotype with respect to growth rate and gene transcription” (Donlan and 
Costerton, 2002). From this definition can be derived that biofilm-forming bacteria have a 
unique gene expression pattern that results different to the planktonic counterpart; 
experimentally it was observed that various genes, varying from 1 to 38% of the total genome, 
can be up- or down-regulated during this process (Sauer, 2003). The biofilm is a complex and 
dynamic architecture coordinated by the quorum-sensing communication system and based on 
five steps involving: i) attachment, ii) aggregation, iii) accumulation, iv) maturation and v) 
detachment (Otto, 2009). 
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Staphylococcal attachment is the first and most important moment in biofilm formation, 
without the commitment between the cell surface and the host, the colonization and infection 
could not easily happen. The expression of proteins devoted to bacterial adhesion to the host 
tissues remains fundamental. The family of Microbial Surface Components Recognizing 
Adhesive Matrix Molecules (MSCRAMMs) together with wall teichoic acid (WTA) and 
adhesins/autolysins (AltE and Aea) play a crucial role in the initial attachment (Arciola et al., 
2005; Kong et al., 2006; Otto, 2009; Cue et al., 2012). The presence of covalent bonds is 
ensured by a family of enzymes (sortase) that link the bacterial peptidoglycan to the conserved 
motif expressed in MSCRAMMs (Mazmanian et al., 1999). 
Subsequently, during the aggregation and accumulation phases, the production of 
Polysaccharide Intercellular Adhesin (PIA)/poly-N-acetylglucosamine (PNAG) ensures the 
cell-to-cell adhesion process. The synthesis of PIA is controlled by the icaADBC locus which 
gives the ability to produce PNAG in ica-dependent biofilm producers (Cue et al., 2012; 
Casagrande Proietti et al., 2015). The extracellular matrix is mainly composed of 
exopolysaccharides (PNAG), proteins (e.g. Bap, Aap, fibronectin-binding proteins FnbPs) and 
extracellular DNA (eDNA) (Arciola et al., 2005, 2012). Staphylococci are also able to produce 
biofilm through an ica-independent pathway mainly controlled by biofilm-associated protein 
(Bap) and Accumulation Associated Protein (Aap) (Kirmusaoglu, 2016).  
A mature biofilm has a specific three-dimensional structure which has been defined as 
“tower” or “mushroom” (Costerton et al., 1999). In between these structures, there are water 
channels that are believed to have a crucial function in the physiology of the biofilm itself 
because are devoted to the delivery of nutrients to cells in deeper layers(Götz, 2002; Otto, 
2004). A progressive decrease in oxygen levels and nutrient delivery was observed in the deeper 
biofilm layers; at this level, bacterial cells have a particular gene expression pattern and a 
quiescent metabolism (Dhanawade et al., 2010; Singh et al., 2013; Stefanetti et al., 2017). 
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Finally, in the detachment phase, bacteria detach from the mature matrix and disperse 
throughout the host tissues. Several factors may drive the detachment: i) mechanical forces, ii) 
suspension of exopolysaccharide production, iii) detachment factors (e.g. enzymes). Via 
quorum-sensing, bacteria communicate with each other to detach from the surface (Shopsin et 
al., 2003; O’Gara, 2007). An in vivo study focused on S. epidermidis showed how this step 
depends on a well-characterized quorum-sensing system, using agr mutant bacteria in a rabbit 
model for medical device-related infection (Vuong et al., 2004). This locus directly controls 
some crucial pathways up-regulating acute virulence factors and down-regulating surface 
proteins involved in bacterial adhesion (Otto, 2004, 2009). 
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Aim 
The introduction section reviewed current knowledge concerning Staphylococcus 
pseudintermedius (SP). Deep bibliographic research was fundamental to describe its molecular 
typing approaches and provide strong data about the genetic structure of the circulating clones. 
The antibiotic-resistance screening of dog-derived strains remains a basic element to support 
Veterinary clinicians in the prescription of the most effective antibiotic in a one-health vision 
of both human and animal Medicine. The plastic genome of all staphylococcal species helps 
bacteria to exchange genetic information, resulting in the acquisition of new genetical traits that 
undergo natural selection. Quite all the knowledge about the virulence determinants properly 
possessed by S. pseudintermedius is resumed in the relative chapter, making sometimes 
comparisons with S. aureus. In the last decades, biofilm has raised as a new and powerful enemy 
to fight against, especially due to its natural antibiotic resistance and the rapid spread, between 
the bacteria encased inside the slime structure, of antibiotic-resistance genes. 
To address these issues, the first aim of the thesis was to describe the genetic structure 
of a population of SP, isolated from canine pyoderma and Holstein-Friesian’s milk, using 
molecular typing techniques and determine the dissemination of specific virulence determinants 
(Chapter 1). 
The description of antibiotic-resistance was the second aim of the thesis. Two large 
populations of SP, isolated in two Italian veterinary teaching hospitals, were compared in terms 
of antibiotic-resistance to a common panel of veterinary prescribed antibiotics. We coupled the 
phenotypic analysis with the genetic amplification of antibiotic-resistance genes (Chapter 2).  
The disease is the result of the interaction between host and microorganisms. The 
unbalance of one lead in the victory of the second. For this reason, the third aim of this thesis 
was the description of the quorum-sensing pathway and the determination of the ability to form 
biofilm using both MDR and non-MDR SP strains (Chapter 3).  
Aim 
 
37 
 
Thereafter, the last chapter is based on the use of silver nanoparticles as an alternative 
strategy to fight against infectious pathogens. 
 
  
Chapter one 
 
38 
 
 
 
 
 
 
 
 
 
 
Chapter 1 
 
 
  
Chapter one 
 
39 
 
Molecular characterization of Staphylococcus pseudintermedius strains isolated from deep 
pyoderma in dogs and cows 
 
 
Gabriele Meroni*, Stefano Morandi, Milena Brasca and Piera A. Martino* 
 
 
 
 
 
*Department of Veterinary Medicine, Università degli Studi di Milano, Via 
dell’Università 6, Lodi 26900, Italy 
 
Institute of Sciences of Food Production-National Research Council (ISPA-CNR), Via 
Celoria 2, Milan, 20133, Italy 
 
Correspondence: Piera A. Martino, Department of Veterinary Medicine, Università 
degli Studi di Milano, Via dell’Università 6, Lodi 26900, Italy. E-mail: piera.martino@unimi.it 
 
 
 
 
 
 
 
Conflicts of interest 
 
The authors declare that they have no conflict of interest 
Funding  
This research did not receive any specific grant from funding agencies in the public, 
commercial, or not-for-profit sectors 
 
 
Article in preparation 
  
Chapter one 
 
40 
 
Abstract 
Background – Staphylococcus pseudintermedius is considered one of the main 
causative agents of canine pyoderma and regarded as a potential zoonotic pathogen. 
Hypothesis/Objective – To investigate the genetical relatedness of S. pseudintermedius 
strains isolated from dogs and cows  
Animal – Samples were collected from 42 dogs with clinical deep pyoderma and 5 cows 
with intramammary infection (IMI). 
Methods and materials – The Restriction Fragment Length Polymorphism PCR 
(RFLP-PCR), the Ribosomal Spacers Amplification PCR (RSA-PCR) and the Random 
Amplification of Polymorphic DNA (RAPD-PCR) were coupled with the sequencing of sodA, 
pheS, and rpoA genes. The detection of specific exfoliative toxins genes (siet, expA, and expB), 
enterotoxin seCcanine and bicomponent leukotoxin lukS-I/lukF-I was used to screen the 
pathogenicity potential of the strains. 
Results – The sequencing revealed that 40 out of 47 original strains were S. 
pseudintermedius the remaining 7 were not the expected species. This result was in accordance 
with all the typing techniques used. RSA-PCR revealed the presence of a single biotype for all 
the interested strains while RAPD-PCR showed a clear genetic relatedness also between canine 
and the 5 bovine staphylococcal strains. All the isolates were positive for the siet gene, while 
expA and expB were amplified by, respectively, 10% and 17,5%. Specific genes for enterotoxin 
seCcanine and leukotoxin luk-I were respectively found in 35% and 92,5% of staphylococci. 
Conclusions and clinical importance – The results confirm at the genetic level the 
relatedness between strains from both dogs and bovine, underlying the potential transmission 
to humans too. 
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Introduction 
 
Staphylococcus pseudintermedius is a normal component of the skin and mucosae of 
dogs and cats and can be isolated from nares, mouth, pharynx, and anus (Devriese et al., 2005). 
It is also a commensal pathogen regarded as the leading cause of skin (pyoderma), ear and post-
surgical infections in dogs (van Duijkeren et al., 2011; Bannoehr and Guardabassi, 2012; 
Tabatabaei et al., 2019). This pathogen is one of the last added members in the Staphylococcus 
genus, being described in 2005 in dogs and pigeons (Devriese et al., 2005), firstly isolated in 
human in 2006 (Van Hoovels et al., 2006) and with a molecular identification protocol available 
from 2009 (Bannoehr et al., 2009). In recent years, the description of S. pseudintermedius as a 
human pathogen is being increasingly reported in particular for the global spread of methicillin-
resistant clones (MRSP) (Little et al., 2019). The incidence of MRSP strains has increased 
significantly in the past few years and has emerged as an important problem because of 
multidrug resistance-associated to oxacillin resistance and the limited number of antibiotics 
choices remaining to face with infections caused by this microorganism (Kang et al., 2014; 
Stefanetti et al., 2017). 
As a member of the Staphylococcus genus, S. pseudintermedius has an extensive panel 
of virulence factors, some of them are closely related to those expressed by S. aureus (van 
Duijkeren et al., 2011). The majority of these are firstly involved in the colonization of host 
tissues and in the dissemination in the colonized district. In particular, exfoliative toxins (siet, 
expA, and expB) are virulence factors involved in canine pyoderma, mainly found among 
staphylococcal strains isolated from skin infections (Futagawa-Saito et al., 2009; Iyori et al., 
2010; Yoon et al., 2010 a,b). The cytotoxic potential of these proteins was studied in dogs in 
2003 by Terauchi revealing that dogs underwent local injection of purified exfoliative toxins 
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develop pathognomonic signs of clinical pyoderma such as erythema, exfoliation, and crusting 
(Terauchi et al., 2003). 
In this study, 40 S. pseudintermedius strains out 47 isolates from clinical cases of deep 
pyoderma were analyzed with three commonly used typing techniques (RFLP-PCR, RSA-PCR, 
and RAPD-PCR) to determine their genetic relation. Moreover, the presence of gene coding for 
staphylococcal exfoliative toxins (siet, expA, and expB), bicomponent leukotoxin (lukS-I and 
lukF-I) and enterotoxin seCcanine by previously reported PCR. 
 
Materials and methods 
Bacterial isolation and phenotypic identification 
 
A total of 47 samples were included in this study: forty-two were obtained from clinical 
cases of deep canine pyoderma (cutaneous swabs), and five from the milk of Holstein-Fresian 
bovines with intramammary infection. Bacteria were isolated in the Microbiology Laboratory 
of the Department of Veterinary Medicine (University of Milan) while the molecular 
characterization was performed at the molecular microbiology laboratory of the Institute of 
Sciences of Food Production (Milan) - National Research Council (ISPA-CNR). 
Cutaneous swabs were plated on TSA+5% sheep blood (Microbiol, Uta, Italy) and 
incubated aerobically at 37°C for 24 hr. Following the morphological characteristics of 
Staphylococcus genus (colonies whit white appearance, regular shape, and total or partial 
hemolysis), the suspected staphylococcal colonies were sub-cultured on Mannitol Salt Agar 
(MSA, Microbiol, Italy) and incubating at 37°C for 24 hours. A single isolated colony from 
MSA was grown in 10 ml of Brain Heart Infusion broth (BHI, Scharlau, Barcelona, Spain) and 
incubated at 37°C for 24 hr. The purity of the isolates was checked by streaking repeatedly on 
Homofermentative-Heterofermentative Differential (HHD) (Biolife, Milan, Italy) agar and sub-
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culturing using the same isolation media and temperatures. After purification, the strains were 
also examined using standard techniques: Gram stain, catalase and coagulase test. 
For the five samples from bovine, milk sample analysis was carried out following the 
National Mastitis Council guidelines (Adkins et al., 2017). The isolates were cultured in 10 ml 
of BHI broth and, after incubation at 37°C for 24 hr, stored at +4°C for further analysis. The 
strains were also stored in duplicate; in sterile milk at -20°C and in 25% of glycerol at -20°C. 
 
DNA extraction 
The DNA was extracted starting from 1 ml of overnight bacterial culture containing 
approximately 2x109 CFU/ml (spectrophotometrically measured at 550 nm) (LabSystem 
Multiskan Plus, Thermofisher Scientific) using the commercial kit DNA Isolation System 
(Clonit, Milan, Italy) according to the manufacturer’s instructions. After the extraction, the 
amount of DNA was checked for its quantity and quality using a spectrophotometer 
(BioPhotometer, Eppendorf, Hamburg, Germany). Approximately an average of 82 ng/µL was 
obtained from 109 CFU/ml. 
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Target gene  Oligonucleotide sequence (5’-3’) Amplicon 
size (bp) 
Reference 
16S-23S F GAAGTCGTAACAAGG * 
(Jensen et al., 1993) 
R CAAGGCATCCACCGT 
pta 
F AAAGACAAACTTTCAGGTAA 320 (Bannoehr et al., 
2009) R GCATAAACAAGCATTGTACCG 
siet 
F ATGGAAAATTTAGCGGCATCTGG 359 
(Lautz et al., 2006) 
R CCATTACTTTTCGCTTGTTGTGC 
expA 
F GTKTTAATTGGWAAAAATACA 413 (Futagawa-Saito et 
al., 2009) R ATNCCWGAKCCTGAATTWCC 
expB 
F GGGCATGCACATATGATGAAGCC 843 
(Iyori et al., 2010) 
R CCAGATCTATCTTCTGATTCAGC 
rpoA 
F ATGATYGARTTTGAAAAACC 820 
(Naser et al., 2005) 
R ACHGTRTTRATDCCDGCRCG 
pheS 
F CAYCCNGCHCGYGAYATGC 488 
R CCWARVCCRAARGCAAARCC 
sodA 
F CATAACACTTATGTTACTAAATTAAAA 233 (Heikens et al., 
2005) R ATCTAAAGAACCCCATTGTTC 
seCcanine 
F GGCGGCAATATTGGCGCTCG 271 (Jang Won Yoon et 
al., 2010) R TTACTGTCAATGCTCTGACC 
lukS-I 
F TGTAAGCAGCAGAAAATGGGG 503 
(Futagawa-Saito et 
al., 2004) 
R GCCCGATAGGACTTCTTACAA 
lukF-I 
F CCTGTCTATGCCGCTAATCCA 572 
R AGGTCATGGAAGCTATCTCGA 
M13  GAGGGTGGCGGTTCT * (Hassan et al., nd) 
OPA10  GTGATCGCAG 
* (Andrighetto et al., 
2001) 
* amplicon size depends on the bacterial species 
Table 1 
Primers used in this study 
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Ribosomal Spacers Amplification PCR (RSA-PCR)  
The RSA-PCR was firstly described by Jensen et al (1993) as a test that “facilitates 
genus and species identification of different bacteria without the requirement of identification” 
(Jensen, 1993). According to this author, amplification reactions were carried out in a final 
volume of 25 µL containing 2 µL of DNA extract, 12,5 µL of PCR Master Mix 2X (Thermo 
Fisher Scientific, Massachusetts, USA), 20 pmol each forward and reverse primer (see Table 
1) and 10,1 µL of DNase free water. PCR reactions were ended in a Mastercycler ep Gradient 
S (Eppendorf) with initial denaturation at 94°C for 2 min, followed by 25 cycles of denaturation 
at 94°C for 1 min, annealing at 55°C for 7 min, extension at 72°C for 2 min followed by a final 
extension at 72°C for 7 min. The amplified PCR products were analyzed on 2,5% (w/v) gel 
agarose (Gel Phor, Euroclone, Milan, Italy) in 1X TAE buffer stained with Atlas Clear Sight 
DNA Stain (Bioatlas, Tartu, Estonia) at 100V for 2,5 hours. 
Random Amplification of Polymorphic DNA (RAPD-PCR)  
RAPD-PCR was performed with two universal primers taken from literature: M13 and 
OPA 10. The amplification reaction consisted of 1 µL of DNA extract in a total volume of 25 
µL composed of 2,5 µL MgCl 10 X Buffer (Finnzymes, Espoo, Finland), 5mM each dNTPs 
(Finnzymes, Espoo, Finland), 125 pmol of primer and 2 U DyNazyme II DNA Polymerase 
(Finnzymes). PCR reactions were carried out in a Mastercycler ep Gradient S (Eppendorf) 
following the conditions described below: (i) M13: 35 cycles of denaturation at 94°C for 1 min, 
annealing at 40°C for 20 seconds, extension at 72°C for 2 min followed by a final extension 
step at 72°C for 7 min. (ii) OPA 10: 40 cycles of denaturation at 94°C for 1 min, annealing at 
37°C for 1min, extension at 72°C for 1,5 min followed by a final extension at 72°C for 7 min. 
DNA fragments were analysed by electrophoresis on 1,5% (w/v)agarose gel (GelPhor) in 1X 
TAE at 100V for 1hr.The RAPD-PCR profiles analysis was done with Gel Compar vers. 5.0 
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software (Applied Maths, Sint-Martens-Latem, Belgium), using the Pearson product-moment 
correlation coefficient and UPGMA cluster analysis. 
Sequencing 
In order to be sure about the phenotypic identification, the sequencing of all the strains 
has been performed. The following genes were chosen from literature and amplified using the 
same conditions described by authors: sodA, rpoA, and pheS (Naser et al., 2005). After 
amplification, the PCR products were analyzed on 1% (w/v) agarose gel (GelPhor) and then 
purified using the commercial kit Wizard® SV Gel and PCR Clean-up System (Promega, 
Wisconsin, USA) according to manufacturer’s instructions. The purified PCR products were 
sent to Macrogen Europe (Macrogen, Amsterdam, Netherlands) for sequencing. The deduced 
nucleotide sequences were analyzed with the BLAST programs (National Center for 
Biotechnology Information, NCBI) for the homology search 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi). 
Restriction Fragment Length Polymorphism PCR (RFLP-PCR)  
As previously described by Bannoehr in 2009, this assay is based on the amplification 
of the pta gene (coding for phosphotransacetylase) followed by the enzymatic digestion with 
MboI. For the enzymatic restriction, performed in a final volume of 20 µL, 1 µL of Anza 55 
MboI (Thermo Fisher Scientific), 8 µL of PCR products and 2 µL of 10X Red Anza Buffer 
(ThermoFisher Scientific) were used. After digestion at 37°C for 15 min, was performed the 
electrophoretic analysis on 2% (w/v) agarose gel at 100V for 1 h. The gel was photographed 
under ultraviolet light. 
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Virulence factors 
As a member of the Staphylococcus genus, also S. pseudintermedius is able to produce 
a panel of different virulence factors. The specific genes are reported in Table 1. Predicted 
amplicon size and primers specificity were defined using BLAST search available through the 
National Center for Biotechnology Information website (www.ncbi.nlm.nih.gov) and coupled 
with BioEdit freeware software (https://omictools.com/bioedit-tool). Either the amplification 
condition and amplicon size were available by the references indicated in table 1. The 
amplification for each gene was carried out with PCR Master Mixer (2X) (ThermoScientific, 
Italy) following the manufacturer’s instructions in a final volume of 25 µL. 
Results  
RSA-PCR 
The amplification of 16S-23S spacers created a set of bands specific for the 
characterization of different species of staphylococci. Fig. 1 showed the pattern of bands 
(biotypes) for some strains of interest. It appeared clear, on the 47 strains analyzed, the presence 
of seven patterns that were different from the majority. Each one represented a bacterium 
belonging to the staphylococcal genus but not the interesting species. In particular, 5 of these 
profiles were the same, suggesting the presence of five strains belonging to the same species 
but still different from the interested one. More in detail, the pattern of S. pseudintermedius 
consisted of three bands between 450 bp and 650 bp. Focusing on this profile and according to 
some previous studies made on S. aureus (Cremonesi et al., 2005; Bardiau et al., 2016; Graber, 
2016), S. pseudintermedius strains here analyzed didn’t have different biotypes supporting the 
hypothesis of lack of interspecies variation. 
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Figure 1 
RSA-PCR profiles of some analyzed strains. (A) lanes 1-4 S. pseudintermedius profiles, 
M: 100 bp molecular marker. (B) profiles of the 7 non-S. pseudintermedius strains. Lanes 1-5 
S. schleiferi, lane 6 S. aureus, lane 7 E. faecalis; M: 100 bp molecular marker. 
 
RAPD-PCR 
The presence of species different from S. pseudintermedius appeared also clear by the 
RAPD-PCR analysis with the primers M13 and OPA 10 (Fig. 7). At 90% of similarity two 
clusters were shown. The first one grouped 40 strains, 35 (87,5%) came from dogs and 5 
(12,5%) from cows. In this case, could be noted the genetic similarity between the canine 
isolates and the five of bovine. The second was composed of 7 different strains in concordance 
with the RSA-PCR profiles findings, in fact, 5 out of 7 strains showed a high degree of genetic 
similarity. 
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Figure 2  
Dendrogram derived RAPD-PCR profiles generated with primers M13 and OPA10. The 
amplification of specific virulence factors is reported near each strain. 
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Sequencing 
As described above, the sequencing involved all the strains subject of this study. Despite 
Sasaki et al (2007) suggestions, sodA wasn’t the most discriminative gene for the identification 
of S. pseudintermedius; in fact, after aligning the sequences of sodA, pheS, and rpoA in BLAST 
the percentage of correct identification were 83% (25/30), 93% (13/14) and 70% (7/10) 
respectively. In concordance with the results obtained with the previous techniques, the 
sequencing clarified the presence of strains belonging to the Staphylococcus genus but not at 
the interesting species. on the 47 strains analyzed in this study, 40 were identified as S. 
pseudintermedius the remaining 7 were different species. in particular, 5 strains of S. schleiferi, 
1 of S. aureus and 1 of Enterococcus faecalis. The last one was thought to be a contaminant, 
from the literature it could be able to grow on MSA and misidentified as S. pseudintermedius. 
For this reason, the research for exfoliative toxins was conducted over the S. pseudintermedius 
strains only. 
RFLP-PCR 
As supposed, the enzymatic digestion produced two restriction fragments: the first of 
213 bp and the second of 107 bp in all S. pseudintermedius strains Fig. 3. According to 
Bannoehr et al., (2009) also S. aureus contained a single MboI restriction site that produced 
two fragments of 156 bp and 164 bp. Unfortunately, the electrophoretic analysis on 2% (w/v) 
agarose gel wasn’t able to separate these two fragments, resulting in the visualization of a single 
band. All the other 6 strains of different species were positive for pta detection but didn’t 
contain any MboI restriction site resulting in the lack of fragments generation. 
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Figure 3  
RFLP-PCR of some strains. Lane 1 pta from S. aureus, lane 2 pta from S. schleiferi, 
lane 3 pta from E. faecalis. Lanes 4-7 pta from S. pseudintermedius. The lanes with final “d” 
contain cleaved pta amplicons. Only pta amplicons of S. pseudintermedius strains present two 
fragments.  
 
Virulence factors 
The prevalence of the virulence factors was calculated only on the 40 S. 
pseudintermedius strains and reported in Fig. 4. Fig. 2 illustrates the dissemination of the 
virulence determinants among each strain. The PCR results demonstrated that all the strains 
carried the siet gene, while expA and expB were found in 10% and 17,5% respectively. Only 
one strain carried these three genes. Thirty-seven strains out 40 were positive for the leukocidin 
gene while the 35% carried seCcanine. 
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Figure 4  
Distribution (%) of the virulence determinants among the 40 S. pseudintermedius strains 
 
Discussion  
The genetic similarity of the 40 staphylococcal strains was clear by RAPD-PCR and, 
coupled with RSA profiles, allows the identification of three distinct sub-groups inside the 40 
S. pseudintermedius strains (1a, 1b, 1c). From literature, it was not so common to isolate S. 
pseudintermedius from bovine because traditionally it was related to cutaneous disease in dogs, 
in addition in this study, this pathogen was found in milk (Bannoehr and Guardabassi, 2012). 
It has to be taken in account that in the majority of bovine farms the presence of guardian dogs 
is a common finding, so we hypothesize that the original reservoir of S. pseudintermedius has 
to be found in guardian dogs that could have infected bovine leading in the intramammary 
infection development (Igbinosa et al., 2016).  
Among the virulence determinants analyzed in this study, siet and the gene coding for 
the bicomponent leukocidin were the two most representative with the highest prevalence 
respectively about 100% and 92,5% among the 40 strains. One of the most interesting 
observations is that 14/40 (35%) staphylococcal strains carried both siet and seCcanine genes 
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while in the study of Yoon (2010 a) the authors found a lower prevalence about 24%. The 
second most interesting finding is that 13/40 (32.5%) isolates simultaneously carry siet, 
seCcanine and lukI genes. Staphylococcal exfoliative toxins act like “molecular blades” while 
bacteria penetrate the skin by cleaving cell-to-cell adhesion proteins. In that sense staphylococci 
that carry at the same times genes coding for exfoliative toxins and leukocidins may better 
penetrate and reverse the immune system. It is already known, for S. aureus only, a clear 
correlation between RSA profile and the presence of specific virulence factors (genotype B 
[most frequently isolated from IMI ] is associated with sed, sej, sea and lukE; genotype C is 
linked to seg, sec, tst and lukE) (Fournier et al., 2008; Graber et al., 2009); this correlation is 
absent for S. pseudintermedius. The amplification of polymorphic regions between 16S and 
23S sequences has played a crucial role in past typing techniques.  
 
In conclusion, it is clear that strains from dogs and cows share genetic relatedness. The 
presence of a single biotype may be a good finding in terms of genetic variation but the presence 
of different virulence factors highlights a potential zoonotic risk. 
  
Chapter one 
 
54 
 
References  
 
Adkins, P.R.F., Middleton, J.R., Fox, L.K., Pighetti, G., Petersson-Wolfe, C., 2017. Laboratory 
handbook on bovine mastitis. 
Andrighetto, C., Zampese, L., Lombardi, A., 2001. RAPD-PCR characterization of lactobacilli 
isolated from artisanal meat plants and traditional fermented sausages of Veneto region 
(Italy). Lett. Appl. Microbiol. 33, 26–30. doi:10.1046/j.1472-765X.2001.00939.x 
Bannoehr, J., Franco, A., Iurescia, M., Battisti, A., Fitzgerald, J.R., 2009. Molecular diagnostic 
identification of Staphylococcus pseudintermedius. J. Clin. Microbiol. 47, 469–471. 
doi:10.1128/JCM.01915-08 
Bannoehr, J., Guardabassi, L., 2012. Staphylococcus pseudintermedius in the dog: Taxonomy, 
diagnostics, ecology, epidemiology and pathogenicity. Vet. Dermatol. 23. 
doi:10.1111/j.1365-3164.2012.01046.x 
Bardiau, M., Caplin, J., Detilleux, J., Graber, H., Moroni, P., Taminiau, B., Mainil, J.G., 2016. 
Existence of two groups of Staphylococcus aureus strains isolated from bovine mastitis 
based on biofilm formation, intracellular survival, capsular profile and agr-typing. Vet. 
Microbiol. 185, 1–6. doi:10.1016/j.vetmic.2016.01.003 
Cremonesi, P., Luzzana, M., Brasca, M., Morandi, S., Lodi, R., Vimercati, C., Agnellini, D., 
Caramenti, G., Moroni, P., Castiglioni, B., 2005. Development of a multiplex PCR assay 
for the identification of Staphylococcus aureus enterotoxigenic strains isolated from milk 
and dairy products. Mol. Cell. Probes 19, 299–305. doi:10.1016/j.mcp.2005.03.002 
Devriese, L.A., Vancanneyt, M., Baele, M., Vaneechoutte, M., De Graef, E., Snauwaert, C., 
Cleenwerck, I., Dawyndt, P., Swings, J., Decostere, A., Haesebrouck, F., 2005. 
Staphylococcus pseudintermedius sp. nov., a coagulase-positive species from animals. Int. 
J. Syst. Evol. Microbiol. 55, 1569–1573. doi:10.1099/ijs.0.63413-0 
Chapter one 
 
55 
 
Fournier, C., Kuhnert, P., Frey, J., Miserez, R., Kirchhofer, M., Kaufmann, T., Steiner, A., 
Graber, H.U., 2008. Bovine Staphylococcus aureus: Association of virulence genes, 
genotypes and clinical outcome. Res. Vet. Sci. 85, 439–448. 
doi:10.1016/j.rvsc.2008.01.010 
Futagawa-saito, K., Makino, S., Sunaga, F., Kato, Y., Sakurai-komada, N., Ba-thein, W., 
Fukuyasu, T., 2009. Staphylococcus pseudintermedius 301, 176–180. doi:10.1111/j.1574-
6968.2009.01823.x 
Futagawa-Saito, K., Makino, S., Sunaga, F., Kato, Y., Sakurai-Komada, N., Ba-Thein, W., 
Fukuyasu, T., 2009. Identification of first exfoliative toxin in Staphylococcus 
pseudintermedius. FEMS Microbiol. Lett. 301, 176–180. doi:10.1111/j.1574-
6968.2009.01823.x 
Futagawa-Saito, K., Suzuki, M., Ohsawa, M., Ohshima, S., Sakurai, N., Ba-Thein, W., 
Fukuyasu, T., 2004. Identification and prevalence of an enterotoxin-ralated gene, se-int, 
in Staphylococcus intermedius isolates from dogs and pigeons. J. Appl. Microbiol. 96, 
1361–1366. doi:10.1111/j.1365-2672.2004.02264.x 
Graber, H.U., 2016. Genotyping of Staphylococcus aureus by Ribosomal Spacer PCR (RS-
PCR) e54623. doi:doi:10.3791/54623 
Graber, H.U., Naskova, J., Studer, E., Kaufmann, T., Kirchhofer, M., Brechbühl, M., Schaeren, 
W., Steiner, A., Fournier, C., 2009. Mastitis-related subtypes of bovine Staphylococcus 
aureus are characterized by different clinical properties. J. Dairy Sci. 92, 1442–1451. 
doi:10.3168/jds.2008-1430 
Hassan, M.M., Gaber, A., Attia, A.O., Baiuomy, A.R., n.d. Molecular Characterization of 
Antibiotic Resistance Genes in Pathogenic Bacteria Isolated from Patients in Taif 
Hospitals , KSA. 
Heikens, E., Fleer, A., Paauw, A., Florijn, A., Fluit, A.C., 2005. Comparison of genotypic and 
Chapter one 
 
56 
 
phenotypic methods for species-level identification of clinical isolates of coagulase-
negative staphylococci. J. Clin. Microbiol. 43, 2286–2290. doi:10.1128/JCM.43.5.2286-
2290.2005 
Igbinosa, E.O., Beshiru, A., Akporehe, L.U., Ogofure, A.G., 2016. Detection of methicillin-
resistant staphylococci isolated from food producing animals: A public health implication. 
Vet. Sci. 3. doi:10.3390/vetsci3030014 
Iyori, K., Hisatsune, J., Kawakami, T., Shibata, S., Murayama, N., Ide, K., Nagata, M., Fukata, 
T., Iwasaki, T., Oshima, K., Hattori, M., Sugai, M., Nishifuji, K., 2010. Identification of a 
novel Staphylococcus pseudintermedius exfoliative toxin gene and its prevalence in 
isolates from canines with pyoderma and healthy dogs. FEMS Microbiol. Lett. 312, 169–
175. doi:10.1111/j.1574-6968.2010.02113.x 
Jensen, M.A., Webster, J.A., Straus, N., 1993. Rapid identification of bacteria on the basis of 
polymerase chain reaction-amplified ribosomal DNA spacer polymorphisms. Appl. 
Environ. Microbiol. 59, 945–952. 
Kang, M.H., Chae, M.J., Yoon, J.W., Kim, S.G., Lee, S.Y., Yoo, J.H., Park, H.M., 2014. 
Antibiotic resistance and molecular characterization of ophthalmic Staphylococcus 
pseudintermedius isolates from dogs. J. Vet. Sci. 15, 409–415. 
doi:10.4142/jvs.2014.15.3.409 
Lautz, S., Kanbar, T., Alber, J., Lämmler, C., Weiss, R., Prenger-Berninghoff, E., Zschöck, M., 
2006. Dissemination of the gene encoding exfoliative toxin of Staphylococcus intermedius 
among strains isolated from dogs during routine microbiological diagnostics. J. Vet. Med. 
Ser. B Infect. Dis. Vet. Public Heal. 53, 434–438. doi:10.1111/j.1439-0450.2006.00999.x 
Little, S. V., Bryan, L.K., Hillhouse, A.E., Cohen, N.D., Lawhon, S.D., 2019.  Characterization 
of agr Groups of Staphylococcus pseudintermedius Isolates from Dogs in Texas . mSphere 
4, 1–11. doi:10.1128/msphere.00033-19 
Chapter one 
 
57 
 
Naser, S.M., Thompson, F.L., Hoste, B., Gevers, D., Dawyndt, P., Vancanneyt, M., Swings, J., 
2005. Application of multilocus sequence analysis ( MLSA ) for rapid identification of 
Enterococcus species based on rpoA and pheS genes 2141–2150. 
doi:10.1099/mic.0.27840-0 
Stefanetti, V., Bietta, A., Pascucci, L., Marenzoni, M.L., Coletti, M., Franciosini, M.P., 
Passamonti, F., Casagrande Proietti, P., 2017. Investigation of the antibiotic resistance and 
biofilm formation of Staphylococcus pseudintermedius strains isolated from canine 
pyoderma. Vet. Ital. 53, 289–296. doi:10.12834/VetIt.465.2275.6 
Tabatabaei, S., Najafifar, A., Askari Badouei, M., Zahraei Salehi, T., Ashrafi Tamai, I., 
Khaksar, E., Abbassi, M.S., Ghazisaeedi, F., 2019. Genetic characterisation of methicillin-
resistant Staphylococcus aureus and Staphylococcus pseudintermedius in pets and 
veterinary personnel in Iran: new insights into emerging methicillin-resistant S. 
pseudintermedius (MRSP). J. Glob. Antimicrob. Resist. 16, 6–10. 
doi:10.1016/j.jgar.2018.08.022 
Terauchi, R., Sato, H., Hasegawa, T., Yamaguchi, T., Aizawa, C., Maehara, N., 2003. Isolation 
of exfoliative toxin from Staphylococcus intermedius and its local toxicity in dogs. Vet. 
Microbiol. 94, 19–29. doi:10.1016/S0378-1135(03)00048-8 
van Duijkeren, E., Catry, B., Greko, C., Moreno, M.A., Pomba, M.C., Pyörälä, S., Ružauskas, 
M., Sanders, P., Threlfall, E.J., Torren-Edo, J., Törneke, K., 2011. Review on methicillin-
resistant Staphylococcus pseudintermedius. J. Antimicrob. Chemother. 66, 2705–2714. 
doi:10.1093/jac/dkr367 
Van Hoovels, L., Vankeerberghen, A., Boel, A., Van Vaerenbergh, K., De Beenhouwer, H., 
2006. First case of Staphylococcus pseudintermedius infection in a human. J. Clin. 
Microbiol. 44, 4609–4612. doi:10.1128/JCM.01308-06 
Yoon, Jang W., Lee, G.J., Lee, S.Y., Park, C., Yoo, J.H., Park, H.M., 2010. Prevalence of genes 
Chapter one 
 
58 
 
for enterotoxins, toxic shock syndrome toxin 1 and exfoliative toxin among clinical 
isolates of Staphylococcus pseudintermedius from canine origin. Vet. Dermatol. 21, 484–
489. doi:10.1111/j.1365-3164.2009.00874.x 
Yoon, Jang Won, Lee, K.J., Lee, S.Y., Chae, M.J., Park, J.K., Yoo, J.H., Park, H.M., 2010. 
Antibiotic resistance profiles of Staphylococcus pseudintermedius isolates from canine 
patients in Korea. J. Microbiol. Biotechnol. 20, 1764–1768. doi:10.4014/jmb.1001.01011 
 
  
Chapter two 
 
59 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
  
Chapter two 
 
60 
 
Original article 
 
 
 
Prevalence and antimicrobial susceptibility patterns of canine Staphylococcus 
pseudintermedius strains isolated from two different Italian university veterinary 
hospitals. 
 
G. Meroni1, F.P. Nocera2, P.A. Martino1, L. De Martino2* 
 
1Department of Veterinary Medicine, Università degli Studi di Milano, Via 
dell’Università 6, Lodi 26900, Italy 
2Department of Veterinary Medicine and Animal Production, Università degli studi di 
Napoli “Federico II”, Via Federico Delpino 1, Napoli 80137, Italy 
 
 
 
 
 
 
* Corresponding author. Tel.: +39. 081-2536180 
 E-mail address: luisa.demartino@unina.it. 
 
Article in preparation 
  
Chapter two 
 
61 
 
Abstract 
Staphylococcus pseudintermedius is one of the last added members in the 
Staphylococcus genus, and is considered one of the most frequently isolated bacteria on the skin 
of dogs and, recently, recognized as a zoonotic pathogen able to cause severe diseases also in 
humans. 
This study aimed to identify methicillin-resistant and -susceptible Staphylococcus 
pseudintermedius (MRSP and MSSP) strains isolated from canine skin disorders and to 
determine their antimicrobial resistance patterns. The study was carried out during 2015-2017 
at veterinary microbiology laboratory of two different Italian veterinary teaching hospitals, 
Milan and Naples. 
The statistical comparison of the results from the two different locations revealed 
significant differences of MRSP prevalence, displaying values of 30% (35/116) and 18% 
(23/126) in Milan and Naples, respectively (p-value= 0,0351). 
Furthermore, all the MRSP strains in Milan and 91% in Naples resulted as multidrug-
resistant (MDR). Among the MSSP strains, 7% and 34%, respectively in Milan and Naples, 
resulted MDR showing statistical differences (p-value= <0,0001). 
These results confirmed the differences in MRSP and MSSP prevalence and highlight 
the antimicrobial resistance patterns in the two different geographical areas. However, the high 
prevalence of multidrug resistance in canine S. pseudintermedius strains, either MRSP and 
MSSP, stands out the need for further investigation considering its impact and importance on 
animal and human health.  
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Introduction 
Skin and ear infections in dogs are very commonly caused by Staphylococcus 
pseudintermedius (S. pseudintermedius) since it is a normal inhabitant of the skin and mucosa 
of dogs and cats (van Duijkeren et al., 2011). Thus, S. pseudintermedius is an opportunistic 
pathogen and a leading cause of skin, ear and post-operative wound infections in dogs and 
marginally in cats (Ross Fitzgerald, 2009; van Duijkeren et al., 2011) 
Canine otitis externa and pyoderma are featured consistently as the major diseases 
affecting canine skin system. Bacterial pyoderma is usually triggered by an overgrowth/over 
colonization of normal resident or transient flora. Since S. pseudintermedius is a normal 
commensal of dog, it is the most commonly responsible for canine pyoderma, in particular, 
superficial pyoderma. Precisely, S. pseudintermedius can be isolated from nares, oral mucosa, 
pharynx, forehead, groin, and anus of healthy dogs (Garbacz et al., 2013). 
In the past, the S. pseudintermedius isolates were generally susceptible to β-lactams, 
whose major antimicrobial agent is penicillin, and many other antibiotics. Therefore, 
methicillin-susceptible S. pseudintermedius (MSSP) strains originally circulated in the canine 
population. However, already since 2006 methicillin-resistant S. pseudintermedius (MRSP) 
strains have been isolated in Europe, becoming a relevant problem in veterinary medicine.  
MRSP has been reported with an increasing frequency (Loeffler et al., 2007; Duijkeren 
et al., 2011; Kasai et al., 2016) and they show often multidrug resistance profiles worldwide, 
including resistance to several classes of antimicrobial drugs (Perreten et al., 2010). This 
behavior limits the treatment options and represents a relevant threat to small animal therapy in 
veterinary medicine, challenging infection control measures (Duijkeren et al., 2011; Bannoehr 
and Guardabassi, 2012; Bond and Loeffler, 2012). In fact, there are several reports on isolates 
resistant almost to all antimicrobials authorized for use in veterinary medicine (Wettstein et al., 
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2008; Perreten et al., 2010) inducing veterinarians to use antimicrobials authorized for human 
medicine (Weese and Duijkeren, 2009). 
The S. pseudintermedius virulence potential and its zoonotic transmission should not be 
underestimated, even though it is not often reported. In fact, S. pseudintermedius, particularly 
MRSP, has been sometimes isolated from humans, especially in pet owners. It is worth noting 
that infections caused by S. pseudintermedius in humans are often underreported due to 
inaccurate identification as S. aureus (Van Hoovels et al., 2006; Stegmann et al., 2010; R. 
Somayaji et al., 2016; Ranjani Somayaji et al., 2016; Lozano et al., 2017; Robb et al., 2017). 
As a member of the Staphylococcus genus, S. pseudintermedius has an extensive panel of 
virulence factors, some of them are closely related to those expressed by S. aureus (Duijkeren 
et al., 2011). The majority of these are firstly involved in the colonization of host tissues and in 
the dissemination in the colonized district. In particular, exfoliative toxins (siet, expA, and expB) 
are virulence factors involved in canine pyoderma, mainly found among Staphylococcal strains 
isolated from skin infections (Futagawa-Saito et al., 2009; Iyori et al., 2010; Yoon et al., 2010). 
Staphylococcal exfoliative toxins act like “molecular blades” during the penetration of the 
bacteria through the skin by cleaving cell-to-cell adhesion proteins. In that sense staphylococci 
that carry at the same time, genes coding for exfoliative toxins and leukocidins may better 
penetrate and reverse the immune system. 
For the best knowledge of all the authors, this is the first study focused on a comparison 
in Italy for the description of antibiotic-resistance of S. pseudintermedius. This study aims to 
describe the phenotypic/genotypic features and the antibiotic resistance patterns of both MRSP 
and MSSP strains, isolated from dogs suffering from skin disorders in two different Italian 
veterinary teaching hospitals. 
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Materials and Methods 
Samples collection 
The present study was designed to investigate the isolation of S. pseudintermedius 
strains that had been collected from dogs in the years 2015-2017 from two Italian university 
veterinary hospitals, located in Milan and Naples, during routinary microbiological 
examinations. S. pseudintermedius strains were isolated from dogs with skin disorders (e.g. 
pyoderma, otitis externa). A collection of 242 S. pseudintermedius isolates were included in 
this study; more in details 116 strains were isolated in Milan and 126 in Naples. 
 
Isolation and phenotypic identification of S. pseudintermedius 
Upon arrival at the laboratories, specimens were cultured and streaked on Columbia 
CNA agar (Liofilchem, Italy) and incubated aerobically at 37°C for 24. Suspected 
staphylococcal colonies were firstly identified by standard, rapid screening techniques: colony 
morphology, β-hemolysis, cellular morphology (after Gram’s staining), catalase test and then 
sub-cultured on Mannitol Salt Agar (MSA, Liofilchem, Italy). Each mannitol salt negative 
colony was also subjected to staphylocoagulase (tube coagulase) test (Oxoid, Ltd, UK) to 
confirm their capacity to produce coagulase enzyme. 
Proteomic profile was assessed by Matrix-Assisted Laser Desorption Ionization Time-
of-Flight Mass Spectrometry (MALDI-TOF MS) analysis (Bruker Daltonics, Germany), using 
fresh colonies. Briefly, a bacterial colony was loaded in the plate for mass spectrometry, and 
then 1 µl of the organic matrix (usually cinnamic acid) was added to the sample. Afterward, the 
plate was placed in the equipment for MALDI-TOF MS analysis and the identification was 
based on the score value released by the equipment’s instructions. Values from 2.3 to 1.9 
indicated the best identification of genus and species of staphylococci (Santos et al., 2013, Nisa 
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et al., 2019). All the strains were stored in 25% glycerol (Carlo Erba, Italy) at -20°C until use. 
Before use, samples were thawed at room temperature and 10 μL were plated on Tryptic Soy 
Agar + 1% sheep blood (Microbiol, Italy) and incubated aerobically at 37°C for 24 h. Three or 
four isolated colonies were picked up and used for the analyses. 
 
Genetic identification of S. pseudintermedius 
For the molecular identification of the selected strains, DNA was extracted from fresh 
cultures of each S. pseudintermedius isolates. The bacterial DNA extraction was carried out by 
two different protocols: in Milan, the boiling method was used (Adwan et al., 2014), while the 
commercial kit Isolate II Genomic DNA Kit (Bioline, London, UK) was used in Naples.  
Referring to the first method, 1 to 5 colonies were picked up from the pure cultures of 
the isolated strain and then resuspended in 100 µL of Tris-EDTA 1X (TE 1X) fresh solution 
and then denatured at 100°C for 10 minutes. After centrifugation, the supernatant was used for 
genomic techniques and stored at -20°C. 
The quantity and quality of DNA were determined by a spectrophotometric reading of 
A260/A280 ratio (Eppendorf BioPhotometer 6131) 
Molecular identification, using species-specific nuc gene (Sasaki et al., 2010) was 
performed by single PCR to confirm the identification of S. pseudintermedius strains. DNA 
from S. pseudintermedius ATCC® 49444TM was used as a positive control. The 
oligonucleotide primer sequences and PCR programs are summarized in Table 1. 
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Gene  Primer sequence 5’-3’ Amplicon 
size (bp) 
Amplification program Reference 
nuc 
F TRGGCAGTAGGATTCGTTAA 
926 
94°C 5 min; 94°C 30 s, 
58°C 60s, 72°C 90s, for 30 
cycles; 72°C 5 min. 
(Sasaki et al., 
2010) R CTTTTGTGCTYCMTTTTGG 
mecA 
F AAAATCGATGGTAAAGGTTGGC 
532 
95°C 5 min; 95°C 1 min, 
58°C 1 min s, 72°C 1 min, 
for 30 cycles; 72°C 7 min. 
(Zubeir et al., 
2007) R AGTTCTGCAGTACCGGATTTGC 
tetK 
F GTAGCGACAATAGGTAATAGT 
360 
94°C 15s; 94°C 1min, 
52°C 1min, 72°C 90s, for 
30 cycles; 72°C 5 min 
 
(Strommenger et 
al., 2003) 
R GTAGTGACAATAAACCTCCTA 
tetM 
F AGTGGAGCGATTACAGAA 
158 
R CATATGTCCTGGCGTGTCTA 
 
Table 1 
Primers sequences, amplicon sizes and amplification programs 
 
Antimicrobial susceptibility testing 
The antimicrobial susceptibility testing was performed on 242 canine S. 
pseudintermedius isolates (116 strains in Milan and 126 strains in Naples) by using Kirby-Bauer 
disk diffusion method according to CLSI (Clinical Laboratory and Standards Institute) 
guidelines (CLSI, 2017). The interpretation of susceptibility patterns was recognized as 
sensitive, intermediate and resistant by comparison of the zone of inhibition as indicated by the 
same Guidelines. 
The antibiotics and the relative concentration are reported in Table 2. 
 Antibiotic name  Concentration 
(µg) 
Group 
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1 Amoxicillin + Clavulanic 
acid 
AMC 30 (20/10) Penicillins (β-lactams) 
2 Oxacillin OX 1 Penicillins (β-lactams) 
3 Ceftriaxone CRO 30 Cephalosporins (β-
lactams) 
4 Clindamycin DA 2 Lincosamides 
5 Enrofloxacin ENR 5 Fluoroquinolones 
6 Erythromycin E 15 Macrolides 
7 Gentamicin CN 10 Aminoglycosides 
8 Kanamycin K 30 Aminoglycosides 
9 Tobramycin TOB 10 Aminoglycosides 
10 Tetracycline TE 30 Tetracyclines 
 
Table 2 
List of all antibiotics tested 
 
Amplification of antibiotic-resistance genes (ARg)  
In order to study the dissemination of genes coding for antimicrobial resistance, the 
amplification of the following genes was performed by single PCRs: mecA, and the 
tetracyclines family genes (tetK, tetL, tetM, and tetO). For each reaction, the final volume was 
set to 25 µL including 12,5 µL of 2X Master Mix (ThermoFisher Scientific, Italy), 20 pmol of 
each primer pairs and 10,1 µL of nuclease-free water. The cycling conditions and the 
oligonucleotide sequences were either reported in Table 1. 
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Statistical analysis 
Data derived from experiments were stored in Microsoft Excel. Samples were grouped 
in MRSP and MSSP, according to the resistant profile against oxacillin and the presence of mec 
gene. The antibiotics were statistically studied with the Chi-squared test to verify if the 
dissemination of resistant strains was accidental or not. Cohen's kappa coefficient (k) for 
dichotomous data was used to verify the agreement between phenotypic analyses and PCR 
detection of resistance genes. The strength of the accordance was interpreted according to 
Landis and Koch (Landis and Koch, 1977), who classified agreement in the following 
categories: 0-0.2 as poor; 0.21-0.4 as fair; 0.41-0.6 as moderate, 0.61-0.8 as good; 0.81-1 as 
very good. Chi-squared test and Cohen's kappa coefficient were performed with GraphPad 
Prism v6 (GraphPad Software®, USA) and Microsoft Excel, respectively. 
 
Results 
Fig. 1 and Supplementary Table 1 report the frequency of resistance to the antibiotic 
molecules tested among the strains from Milan (N=116) and Naples (N=126) and the 
confidence intervals (95%) calculated for the prevalence of resistance to each single antibiotic 
molecules. Despite the similarity in the frequencies of resistance among the two hospitals, four 
molecules (AMC, DA, TOB, and TE) resulted in statistical significance between Milan and 
Naples. More in detail, the strains from Milan showed higher resistance to clindamycin (DA, 
for the abbreviations, see Table 2) and tobramycin (TOB); on the contrary, the resistance against 
AMC and TE was higher in Neapolitan isolates. 
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Fig.1 
Overall prevalence of antibiotic resistance among isolates 
 
The prevalence of methicillin/oxacillin-resistant strains (MRSP) was 30% (35/116) and 18% 
(23/126) in Milan and Naples, respectively; these data resulted in statistical significance (χ2p-
value=0.0351). At a genetic level, the amplification of the mecA gene occurred in all the MRSP 
strains derived from the Kirby-Bauer assay, confirming the phenotypic findings and resulting 
in a total concordance (k=0.9) by Cohen's kappa coefficient. Looking with more detail to the 
MRSP and MSSP populations, the resistance frequencies and statistical differences were totally 
different (Fig. 2). 
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Fig. 2 
Distribution of antimicrobial resistance among MRSP (A) and MSSP (B) strains in 
Milan and Naples. 
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Among the strains from Milan and those from Naples, a clear difference in terms of 
Multi-Drug Resistant (MDR) strains was found; the 35 MRSP strains were also MDR while 
21/23 (91%) of the strains from the second hospital was MDR. The situation in the MSSP 
populations was very different from the one previously described. Strains from Milan exhibited 
a lower resistance compared to those from Naples and resulting in a more divergent MDR 
dissemination: 6/81 (7%) and 35/103 (34%), from Milan and Naples, respectively, resulted as 
MDR. 
Fig. 3 shows the dissemination of the tet family genes between MRSP and MSSP 
populations. No statistical differences were found among the MRSP group, only the 
amplification of tetK gene in MSSP group showed statistical differences between Milan and 
Naples.  
 
Fig. 3 
Prevalence of tet genes amplification among MRSP (up) and MSSP (bottom) 
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Discussion 
Microbial resistance is a normal behavior for bacteria that respond to environmental 
stimuli and, as a consequence, develop resistance as a strategy for surviving (Rodríguez-Rojas 
et al., 2013). Methicillin/oxacillin resistance, in the member of Staphylococcus genus (both 
coagulase-positive and negative), is mediated by the synthesis of a novel penicillin-binding 
protein, the penicillin-binding protein 2a (PBP2a), that confers resistance to all β-lactams and 
is mediated by mecA gene (Fuda et al., 2004). The phenotypic resistance to methicillin/oxacillin 
has to be validated by the amplification of the mecA gene to classify staphylococci as 
methicillin-resistant. Our data provide evidence of a high incidence of MRSP strains in two 
Italian veterinary teaching hospitals about 30% and 18% in Milan and Naples, respectively. 
These results are in partial concordance with the available Italian literature in which was 
reported, in 2017, a prevalence of MRSP of 59% (30/51) (Stefanetti et al., 2017). The situation 
is completely different if compared to Finland (Grönthal et al., 2015) and Germany (Nienhoff 
et al., 2011), in which the dissemination of MRSP was about 3% and 704%, respectively. 
Furthermore, MDR bacteria are defined as resistant to at least three different 
pharmaceutical categories (Magiorakos et al., 2012). In our study, a large proportion of S. 
pseudintermedius strains resulted in MDR and exhibited multiple resistances in particular to 
amoxicillin, clindamycin, erythromycin, kanamycin, and tobramycin, reflecting the over-use of 
these antibiotics as first aid in Veterinary Medicine. Also in this case, our results are in 
accordance with the literature (Casagrande Proietti et al., 2015; Stefanetti et al., 2017). 
Conclusions 
All these findings, once again, should advise a revision in the current over-use of 
antibiotics. The last edition of the Surveillance of antimicrobial resistance in Europe (2018) 
stated that “high levels of resistance remain in the EU/EEA for several bacterial species–
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antimicrobial group combinations” (ECDC, 2018). In Veterinary Medicine, also, national and 
international guidelines for the correct use of antibiotics focus the attention of all the EU 
members to reduce the amount of antibiotics prescribed (Division, 2018; Tacconelli et al., 
2018). One of the most interesting findings, in this study, is the high prevalence of MRSP 
strains. Further studies have to be planned in particular to study the relation between antibiotic-
resistance and biofilm formation. 
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Appendix A: Supplementary materials 
Supplementary Table 1 
Prevalence of antibiotic resistance among S. pseudintermedius strains from Milan and Naples 
Antibiotic Milan (N= 116)  Naples (N=126) 
 Prev (%) (95% CI) (%)  Prev (%) (95% CI) (%) 
AMC 32 (***) 23.5-40.4  64 (***) 55.6-72.3 
OX 30 21.6-38.3  18 11.2-24.7 
CRO 28 19.8-36.1  19 12.1-25.8 
DA 56 (**) 46.9-65  39 (**) 30.4-47.5 
ENR 38 29.1-46.8  25 17.4-32.5 
E 35 26.3-43.6  47 38.2-55.7 
CN 16 9.3-22.6  17 10.4-23.5 
K 35 26.3-43.6  50 41.2-58.7 
TOB 33 (***) 24.4-41.5  5.5 (***) 1.5-9.4 
TE 35 (***) 26.3-43.6  57 (***) 48.3-65.6 
N= number of strains. χ2: * 0.05<p<0.01; ** p< 0.01; *** p< 0.001 
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Abstract 
Staphylococcus pseudintermedius is a commensal bacterium frequently isolated from 
canine skin and recognized as a zoonotic agent especially for dog-owners. This study focused 
on (a) the antibiotic-resistance phenotypes; (b) the ability to produce biofilm (slime); and (c) 
the dissemination of virulence factors in S. pseudintermedius strains. Seventy-three S. 
pseudintermedius strains were screened for antibiotic-resistance against 22 different molecules 
by means of Kirby-Bauer assay. The ability to produce biofilm was investigated using the 
microtiter plate assay (MtP) and the amplification of icaA and icaD genes. Virulence factors 
such as cytotoxins (lukI), enterotoxins (seC), and exfoliative toxins (siet, expA, and expB) were 
evaluated. The antibiotic-resistance profiles revealed 42/73 (57%) multi-drug resistant (MDR) 
strains and 31/73 (43%) not-MDR. All the MDR strains and 8/31 (27%) of not-MDR resulted 
in biofilm producers. Leukotoxin LukI was found in 70/73 (96%) of the isolates. Moreover, the 
enterotoxin gene seC was detected in 47/73 (64%) of the strains. All the isolates carried the siet 
gene, whereas expA and expB were found in 3/73 (4%) and 5/73 (7%), respectively. In 
conclusion, S. pseudintermedius should be considered a potential zoonotic and human agent 
able to carry different virulence determinants and capable of producing biofilm which facilitates 
horizontal gene transfer. 
  
Chapter three 
 
83 
 
Introduction 
Staphylococcus pseudintermedius (SP) is one of the youngest members of the 
Staphylococcus genus, being described and recognized only in 2005 (Devriese et al., 2005), 
with the first reported case in humans in 2006 (Van Hoovels et al., 2006) and the first molecular 
identification protocol in 2009 (Bannoehr et al., 2009). It is an opportunistic pathogen also 
known as one of the leading cause of skin, ear, and post-surgical infections in domestic animals, 
especially in dogs (Guardabassi et al., 2004; Bartlett et al., 2011; Bannoehr and Guardabassi, 
2012; Little et al., 2019). Even if infections in humans are less common than those reported in 
pets, the description of S. pseudintermedius as a human pathogen is being increasingly reported 
(Starlander et al., 2014; R. Somayaji et al., 2016; Little et al., 2019), however little is known 
about its pathogenesis and distribution, and in human medicine is still misdiagnosed as S. 
aureus (Börjesson et al., 2015). A progressive expansion in resistance to commonly prescribed 
antimicrobial agents has been observed in the past years, in particular with the emergence and 
the global spread of multi drug resistant (MDR) bacteria with particular regards for the 
Methicillin Resistant S. pseudintermedius (MRSP) clones that dramatically complicate the 
treatment of these infections (Stefanetti et al., 2017; Little et al., 2019). 
The ability to form biofilm is one of the major virulence determinants studied nowadays 
in bacteria because it facilitates the adherence to biotic and/or abiotic surfaces (Arciola et al., 
2005). Biofilm-related infections are fastidiously faced because sessile bacteria are generally 
much more tolerant to antibiotics compared to the equivalent planktonic forms and can easily 
resist to host immune responses (Resch et al., 2005). To form a biofilm, bacteria require at least 
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two features: a) Adherence to a surface, and b) the possibility to accumulate it in order to form 
a multi-layered complex structure. The ability to form a biofilm resides in the formation of an 
extracellular matrix known as polysaccharide intercellular adhesion molecule (PIA), that is 
encoded by the ica operon, including four distinct genes (A, B, C, and D) (Arciola et al., 2005; 
Casagrande Proietti et al., 2015; Little et al., 2019). The biofilm forming ability of S. 
pseudintermedius has been reported by different authors but nowadays is still not fully 
understood; in a recent study Stefanetti et al., (2017), up to 96% of canine SP strains was able 
to produce biofilm (Singh et al., 2013; Stefanetti et al., 2017). Moreover, ica-independent 
biofilm formation has been reported in staphylococci (Hennig et al., 2007; O’Gara, 2007; Panda 
and Singh, 2018). 
The aim of the present study is to analyze the possible correlation between antibiotic-
resistance, ability to form biofilm, and dissemination of virulence determinant in different 
isolated strains of SP. 
Materials and Methods 
Bacterial Isolation and Identification 
The 73 S. pseudintermedius strains included in this study were collected between 2016 
and 2018 at the Microbiology Laboratory of the Department of Veterinary Medicine (Università 
degli Studi di Milano). Clinical samples were cultivated on Trypticase Soy Agar (TSA) + 5% 
defibrinated sheep blood agar (Microbiol, Uta (CA), Sardinia, Italy) and incubated aerobically 
at 37 °C for 24 h. Following morphological analysis, the suspected staphylococcal colonies 
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were sub-cultured on Mannitol Salt Agar (MSA; Microbiol, Uta (CA), Sardinia, Italy) for genus 
identification and incubated at 37 °C for 24 h. To confirm the isolation of S. pseudintermedius, 
standard phenotypic techniques were used such as Gram stain, catalase test, and coagulase test. 
Finally, the amplification of the nuc gene (Table 1) described by Sasaki in 2010, was used to 
genetically confirm the isolates at species level (Sasaki et al., 2010). All the strains were stored 
at −20 °C in 25% glycerol. 
DNA Extraction 
Pure cultures stocks in glycerol were thawed at room temperature and grown on blood 
agar plates at 37 °C for 24 h. A single colony was picked up and grown in Brain Heart Infusion 
Broth (BHI, Scharlau, Spain) at 37 °C for 8 h. One mL aliquot was used for DNA extraction 
using the previously described boiling method (Adwan, 2014). DNA was quantified and 
checked for its purity using the NanoDropTM 2000 Spectrophotometer (Thermo Fisher 
Scientific, Monza (MB), Lombardy, Italy). 
Molecular Typing 
In order to better characterize the S. pseudintermedius strains, two commonly used 
typing techniques were used: MultiLocus Sequence Typing (MLST) and SCCmec Typing. 
Genetic diversity of the strains was determined by MLST of seven genes (tuf, cpn60, 
pta, purA, fdh, ack, sar); the primers used as well as the amplification conditions were the same 
as those previously described by Solyman et al. (2013) (Solyman et al., 2013). MLST sequences 
were aligned with sequences present in the NCBI nucleotide database in order to set out the 
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allele number. Sequence types (STs) were assigned according to the literature (Bannoehr et al., 
2007) and using Staphylococcus pseudintermedius MLST database 
(https://pubmlst.org/spseudintermedius/). 
SCCmec types I–VI were assigned, among MRSP strains only, using a specific set of 
multiplex PCR assays as reported by different authors, using the same set of primers and 
amplification conditions previously described (Kadlec et al., 2010; Perreten et al., 2010). 
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Table 1. Primers, amplicon size, and amplification conditions. 
 Genes  Sequence (5’-3’) 
Amplicon Size 
(bp) 
PCR Conditions References 
Antibiotic-
resistance genes 
mecA 
F AAAATCGATGGTAAAGGTTGGC 
532 
95 °C × 4 min, 30 x (95 °C x 1 min, 58 °C x 1 min, 72 
°C × 1 min) 72 °C × 7 min, 4 °C 
(Kang et al., 2014) 
R AGTTCTGCAGTACCGGATTTGC 
blaZ 
F TGACCACTTTTATCAGCAACC 
750 
R GCCATTTCAACACCTTCTTTC 
tetK 
F GTAGCGACAATAGGTAATAGT 
360 
94 °C × 3 min, 30 × (94 °C × 30 s, 55 °C × 30 s, 72 
°C × 30 s) 72 °C × 7 min, 4 °C 
(Strommenger et al., 
2003) 
R GTAGTGACAATAAACCTCCTA 
tetM 
F AGTGGAGCGATTACAGAA 
158 
R CATATGTCCTGGCGTGTCTA 
aacA-
aphD 
F TAATCCAAGAGCAATAAGGGC 
227 
R GCCACACTATCATAACCACTA 
Biofilm genes 
icaA 
F ACTGTTTCGGGGACAAGCAT 
134 
94 °C × 3 min, 35 × (94 °C × 15 s, 60 °C × 20 s, 72 
°C × 20 s) 72 °C × 7 min, 4 °C 
(Resch et al., 2005) 
R ATTGAGGCTGTAGGGCGTTG 
icaD 
F CGTTAATGCCTTCTTTCTTATTGCG 
166 
94 °C × 3 min, 35 × (94 °C × 15 s, 56 °C × 20 s, 72 
°C × 20 s) 72 °C × 7 min, 4 °C R ATTAGCGCACATTCGGTGTT 
Quorum-sensing 
genes 
pan-agr F ATGCACATGGTGCACATGC 
 
94 °C × 3 min, 35 × (94 °C × 15 s, 56 °C × 20 s, 72 
°C × 20 s) 72 °C × 7 min, 4 °C 
(Shopsin et al., 2003) 
agrI R GTCACAAGTACTATAAGCTGCGAT 
agrII R GTATTACTAATTGAAAAGTGCCATAGC 
agrIII R CTGTTGAAAAAGTCAACTAAAAGCTC 
agrIV R CGATAATGCCGTAATACCCG 
Virulence factors 
luk-F 
F CCTGTCTATGCCGCTAATCCA 
572 
94 °C × 3 min, 35 × (94 °C × 1 min, 57 °C × 1 min, 
72 °C × 1 min) 72 °C × 7 min, 4 °C 
(Futagawa-Saito et 
al., 2004) 
R AGGTCATGGAAGCTATCTCGA 
luk-S 
F TGTAAGCAGCAGAAAATGGGG 
503 
R GCCCGATAGGACTTCTTACAA 
seC 
F GGCGGCAATATTGGCGCTCG 
271 
95 °C × 2 min, 30 × (95 °C × 1 min, 55 °C × 1 min, 
72 °C × 2 min) 72 °C × 5 min, 4 °C 
(Yoon et al., 2010) 
R TTACTGTCAATGCTCTGACC 
nuc 
F TRGGCAGTAGGATTCGTTAA 
926 
95 °C × 2 min, 30 × (95 °C × 30 s, 52 °C × 30 s, 72 
°C × 30 s) 72 °C × 2 min, 4 °C 
(Sasaki et al., 2010) 
R CTTTTGTGCTYCMTTTTGG 
siet 
F ATGGAAAATTTAGCGGCATCTGG 
359 
94 °C × 3 min, 30 × (94 °C × 30 s, 56 °C × 30 s, 72 
°C × 1 min) 72 °C × 5 min, 4 °C 
(Lautz et al., 2006) 
R CCATTACTTTTCGCTTGTTGTGC 
expA 
F GTKTTAATTGGWAAAAATACA 
413 
94 °C × 3 min, 30 × (94 °C × 1 min, 42 °C × 1 min, 
72 °C × 1 min) 72 °C × 4 min, 4°C 
(Futagawa-Saito et 
al., 2009) R ATNCCWGAKCCTGAATTWCC 
expB 
F GGGCATGCACATATGATGAAGCC 
820 
95 °C × 3 min, 30 × (95 °C × 1 min, 53 °C × 1 min, 
72 °C × 1 min) 72 °C × 4 min, 4 °C 
(Iyori et al., 2010) 
R CCAGATCTATCTTCTGATTCAGC 
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Determination of Antibiotic-Resistance Profile 
Kirby-Bauer Disk Diffusion Method 
Susceptibility to a panel of 22 antimicrobial agents was determined by the Kirby-Bauer 
disk diffusion test according to the Guidelines of the Clinical Laboratory and Standards Institute 
(CLSI, 2015). Disks of 22 different antibiotics were used as reported below (in brackets the 
concentration in µg): Oxacillin (OX, 5), Amoxicillin + Clavulanic acid (AMX, 30 [20/10]), 
Amoxicillin (AML, 30), Carbenicillin (CAR, 100), Cephalexin (CL, 30), Cefovecin (CVN, 30), 
Ceftiofur (EFT, 30), Ceftriaxone (CRO, 30), Clindamycin (DA, 10), Lincomycin + 
Spectinomycin (MY, 15 [5/10]), Doxycycline (DO, 5), Enrofloxacin (ENR, 5), Marbofloxacin 
(MAR, 5), Pradofloxacin (5, 5), Amikacin (AK, 30), Gentamicin (CN, 30), Neomycin (N, 30), 
Tobramycin (TOB, 10), Kanamycin (K, 30), Rifampicin (RD, 30), Azithromycin (AZM, 15), 
Erythromycin (E, 30). The results were recorded as susceptible, intermediate, or resistant by 
the measurement of the inhibition halo diameter. 
Amplification of Antibiotic-Resistance Genes (ARg) 
The primers used for the detection of five different antibiotic-resistance genes (ARg) 
were taken from the literature (Strommenger et al., 2003; Zubeir et al., 2007; Kang et al., 2014), 
synthesized by Eurofins Genomics, and listed in Table 1. Predicted amplicon size and primers 
specificity were defined using BLAST search available through the National Center for 
Biotechnology Information website (www.ncbi.nlm.nih.gov) and coupled with BioEdit 
freeware software. To check specificity on DNA from genotypically defined isolates, single 
PCRs for each primer pair were performed before the Multiplex PCR assay. 
For tetK, tetM, and aacA-aphD genes, the protocol described by Strommenger in 2003 
was followed (Strommenger et al., 2003). Multiplex PCR amplifications were carried out with 
AccuPrimeTM Taq DNA Polymerase system (Invitrogen, Italy) following the manufacturer′s 
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instruction in a 25 µL volume comprising approximately 40 ng of DNA, 10 pmol of each of 6 
primers, 2.5 µL of 10× AccuPrimeTM PCR Buffer II, 4 nM of MgCl2 (final concentration), 0.3 
U of AccuPrimeTM Taq DNA Polymerase, and nuclease-free water (NFW) to reach the final 
volume. 
For mecA and blaZ genes, the protocol used was described by Kang in 2014 (Kang et 
al., 2014). Multiplex amplifications were carried out using the same kit previously described. 
The PCR products were resolved on a 1.5% agarose gel (GellyPhoreLE, EuroClone, Italy). 
Biofilm Analysis 
Identification of Biofilm-Forming Strains 
The identification of biofilm-forming strains was carried out by the microtiter plate 
(MtP) assay, as previously described (Stepanovic et al., 2000; Stephanovic et al., 2007). Briefly, 
after growing in BHI broth at 37 °C for 24 h, pure staphylococcal cultures were 1:100 diluted 
in fresh Trypticase broth (Oxoid, Italy) + 1% glucose (TSBg) and seeded in 96 well-plates 
(Corning, USA). After 24 h of incubation at 37 °C, planktonic bacteria were washed out and 
biofilm was stained with Crystal violet (Carlo Erba, Italy). Negative controls consist of TSBg 
only. Each strain was analyzed in triplicate on the same plate and three independent plates were 
used. The absorbance (570 nm) of negative controls was used to set the optical density cut-off 
(ODc) as three standard deviations above the mean OD of the negative control. Strains were 
classified as follows: Not adherent OD ≤ ODc; weakly adherent ODc < OD ≤ 2 × ODc; 
moderately adherent ODc < OD ≤ 4 × ODc; strongly adherent OD > 4 × ODc. 
Amplification of Biofilm-Associated Genes and Agr-Typing 
To confirm data from MtP assay, the detection of two pivotal genes of ica locus (icaA 
and icaD) was performed by conventional qualitative PCR (see Table 1) using primer according 
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to literature (Casagrande Proietti et al., 2015). Taking into account that the ability to produce 
biofilm could be associated with a specific antibiotic-resistance profile (Melchior et al., 2009; 
Little et al., 2019), the agr locus was analyzed with two duplex PCRs for the determination of 
agr type (I-IV), as previously reported (Shopsin et al., 2003). For the two duplex PCRs, the 
already described AccuPrimeTM Taq DNA Polymerase system (Thermo Fisher Scientific, 
Monza (MB), Lombardy, Italy) was used. 
Virulence Factors Carriage 
To establish the pathogenicity of the isolated strains, specific virulence factors (lukS-F, 
seC, siet, expA and expB) were searched by qualitative PCR. Their specific thermal cycling 
conditions and primer pairs are listed in Table 1. 
Statistical Analysis 
Statistical significance was determined by GraphPad Prism v6 (GraphPad Software®, 
La Jolla California, USA) using Fisher′s exact test. Data were analyzed by contingency tables 
(2-by-2 layout). A p-value < 0.05 was considered significant. The agreement between the MtP 
assay and PCR detection of icaA and icaD genes was calculated using Cohen’s Kappa values 
for dichotomous data in Microsoft Excel. The strength of the accordance was interpreted 
according to Landis and Koch (1977), who classified agreement in the following categories: 0–
0.2 as poor; 0.21–0.4 as fair; 0.41–0.6 as moderate, 0.61–0.8 as good; 0.81–1 as very good 
(Landis and Koch, 1977). 
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Results 
Molecular Identification of S. pseudintermedius, MLST, and SCCmec Typing 
All the isolates were from dogs with clinical deep pyoderma, a single 926 bp fragment 
was derived from the amplification of themonuclease gene (nuc) confirming, at species level, 
the phenotypic isolation of 73 S. pseudintermedius strains. 
The 73 isolates were assigned to three different STs with the following prevalences: ST 
71 56/73 (77%), ST 258 12/73 (16.4%), and ST 106 5/73 (6.6%). 
SCCmec types were assigned to 35/76 (48%) strains that resulted positive to mecA gene 
detection and classified as methicillin-resistant S. pseudintermedius (MRSP), resulting in two 
different types, as reported in Table 2. 
Table 2. Molecular characterization of the 35 methicillin-resistant S. pseudintermedius 
(MRSP) isolates. 
MLST SCCmec Types No. of Isolates (%) 
ST 71 II-III 24 (68.5%) 
ST 258 IV 9 (25.7%) 
ST 106 IV 2 (5.7%) 
 
Overall Antibiotic-Resistance 
The antibiotic-resistance of all 73 S. pseudintermedius isolates is shown in Figure 1. 
Kirby-Bauer assay demonstrated that 42/73 (57.5%) of SP isolates were MDR, exhibiting 
resistance against macrolides (97%), fluoroquinolones (86%), and β-lactams (72%). The most 
in-vitro effective molecules were amikacin (100% susceptible), rifampicin (93% susceptible), 
and partially gentamicin (45% susceptible). The remaining 31 not-MDR strains had a low 
prevalence of resistance for all the antibiotics with the exception of clindamycin which had a 
Chapter three 
 
92 
 
rate of resistance of 35% (11/31). Table 3 shows the prevalence of ARg by using Multiplex 
PCRs. 
 
Figure 1. Overall prevalence of antibiotic-resistance among multi-drug resistant (MDR) 
and not-MDR isolates. The Chi-squared test showed statistical differences among the two 
groups for the majority of antibiotic molecules tested except for amikacin and rifampicin. (*: 
p-value between 0.05 and 0.01; **: p-value < 0.01; ***: p-value < 0.001). 
Table 3. Distribution of antibiotic-resistance and virulence factors genes. 
 Genes not MDR Strains MDR Strains p-Value 
Antibiotic-resistance genes 
mecA 0 35/42 (83%) <0.0001 
blaZ 7/31 (23%) 42/42 (100%) <0.0001 
tetK 2/31 (6.4%) 13/42 (31%) 0.0171 
tetM 0 22/42 (50%) <0.0001 
aacA-aphD 5/31 (16.6%) 32/42 (76%) <0.0001 
Biofilm genes 
icaA 30/31 (97%) 29/42 (69%) 0.0026 
icaD 30/31 (97%) 41/42 (97%) >0.05 
Virulence factors 
luk-I 30/31 (97%) 40/42 (95%) >0.05 
seC 14/31 (45%) 31/42 (74%) 0.016 
nuc 31/31 (100%) 42/42 (100%) >0.05 
siet 31/31 (100%) 42/42 (100%) >0.05 
expA 0 3/42 (7%) >0.05 
expB 0 5/42 (12%) >0.05 
 
Biofilm Formation Assay 
Figure 2A shows the difference in terms of number of non-biofilm producing strains 
among not-MDR and MDR strains. Between these two groups, there is a clear difference in 
terms of the ability to produce biofilm (Figure 2B). The MDR bacteria were all able to produce 
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exopolysaccharide, resulting in 20/43 (46.5%) strong biofilm producers, 20/43 (46.5%) 
moderate, and 2/43 (4.6%) weak producers. In the not-MDR group, only 1/31 (3.22%) strains 
was strong producer, 9/31 (29%) strains were categorized as moderate producers, and 17/31 
(55%) resulted in weak biofilm producers. The remaining 4/31 (13%) did not show slime 
production. At the molecular level, the presence of icaA and icaD genes was demonstrated by 
the amplification of the corresponding amplicons. Both the icaA and icaD genes were detected 
in 30/31 (97%) not-MDR strains, while 28/42 (66.6%) of MDR bacteria had both the targeted 
genes. Among the remaining 14 strains, one was negative for both these genes (but still able to 
produce biofilm) and the remaining 13 were all positive for icaD only. Neither one of these 
genes was detected in 2/73 (2.7%) isolates (details are reported in Supplementary Table S1). 
The agreement between the microplate assay and the amplification of ica locus genes was not 
significant (k < 0.01). The determination of agr-typing showed that all the 73 SP strains belong 
to the agr type I. 
 
Figure 2. Biofilm forming ability in not-MDR and MDR Staphylococcus 
pseudintermedius (SP) strains. (a) All the MDR strains are able to produce biofilm and these 
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data are statistically significant compared to the not MDR group in which 4 strains resulted in 
non-biofilm producers. (b) The majority of MDR strains were strongly biofilm producers 
(20/42), whereas not-MDR strains were mostly categorized as weak slime producers. (*: p-
value between 0.05 and 0.01; **: p-value < 0.01; ***: p-value < 0.001). 
Virulence Factors 
Table 2 shows the distribution of all the genes analyzed in this study. Among the 
virulence factors, Chi-squared test showed differences in icaA and seC genes between MDR 
and not-MDR bacteria, for all the other virulence determinants, no differences were found 
(Figure 3). 
 
Figure 3. Dissemination of virulence factors among MDR and not-MDR strains. (*: p-
value between 0.05 and 0.01; **: p-value < 0.01; ***: p-value < 0.001). 
Discussion 
Antibiotic-resistance remains one of the most important problems to face within 
treatment and control of S. pseudintermedius related infection in human and in veterinary 
medicine. SP is nowadays considered a potential zoonotic agent able to colonize also humans 
and is regarded as one of the increasing skin and soft tissue-related pathogens (R. Somayaji et 
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al., 2016; Ranjani Somayaji et al., 2016; Kmieciak and Szewczyk, 2018). MDR strains are 
defined when “resistant to at least 1 agent in 3 or more antimicrobial categories”(Magiorakos 
et al., 2012). In this study, 57.5% (42/73) of the strains had MDR phenotype, also confirmed 
by the detection of AR genes. The majority of the resistant strains 35/42 (83%) resulted positive 
for mecA gene, associated with oxacillin resistance; this result is in concordance with a previous 
study which revealed a 100% of mecA gene amplification in MRSP strains (Moyaert et al., 
2019). A large portion of isolates showed a pattern of resistance against β-lactams, macrolides, 
and fluoroquinolones. 
A total of three STs (ST 71, ST 258 and ST 106) were detected among the 73 SP strains. 
This result is not totally concordant with the literature in which different authors found a higher 
genetic diversity in the analyzed population (in terms of STs assigned) (Damborg et al., 2016; 
Bergot et al., 2018). ST 71 is predominant and was assigned to 56/73 (77%) strains; this 
particular sequence type remains the most abundant in Europe, while ST 68 is predominant in 
United States, and ST 45/ST 112 in Asia (Solyman et al., 2013; Dos Santos et al., 2016). In 
Europe, between 2012–2013 and 2015–2016, the prevalence of ST 71 rapidly decreased from 
65.3% to 55.2%, whereas the emergence of ST 258, originally derived from Northern Europe, 
was described (from 1.1% to 5.78%) (Bergot et al., 2018). ST 71 was highly resistant to 
antibiotics, showing multiple resistances against commonly veterinary-licensed antibiotics 
(e.g., tetracyclines). On the other hand, ST 258 was reported to be more frequently susceptible 
to antibiotics (e.g., enrofloxacin, gentamicin) (Dos Santos et al., 2016; Bergot et al., 2018). 
In this study, all the MRSP strains (35/73; 48%) resulted in MDR, and the majority 
(68.5%) were classified as ST 71. SCCmec typing showed two chromosomal cassettes types: 
II-III present in all ST 71, and IV detected in the other MRSP strains belonging to STs 258/106 
(Table 2). 
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A clear correlation was found between antibiotic-resistance and the ability to produce 
biofilm, suggesting that MDR staphylococci are more prone to produce large quantities of 
slime. This particular result is in accordance with other studies and could be reasonably 
explained by the presence of transposons which are the mobile element that easily can be 
exchanged between strains (Arciola et al., 2005; Casagrande Proietti et al., 2015; Stefanetti et 
al., 2017). 
The majority (94.5%) of the 73 isolates were biofilm producers, and this result is in 
agreement with the current literature on biofilm in Staphylococcus clinical isolates (Rinsky et 
al., 2013; Casagrande Proietti et al., 2015). Moreover, a genetic approach revealed the 
concomitant presence of either icaA or icaD in 79.5% (58/73) of the strains studied, while 18% 
(13/73) of the isolates presented the amplification of icaD and only two strains were negative 
for both these two genes but still able to produce biofilm. Authors suggest that the presence of 
icaD only (found in 42/43 MDR strains) is sufficient to produce exopolysaccharide, as 
demonstrated for S. epidermidis (Arciola et al., 2005). These findings are discordant with a 
previous study (Singh et al., 2013) in which the author suggested that biofilm formation 
occurred only when both icaA and icaD are expressed, but however concordant with another 
study  which reported the absence of correlation between the presence of both ica genes and 
biofilm formation (ica-independent biofilm producers strains). These results suggest the 
importance of combined, phenotypic, and genetic methods for checking biofilm formation in S. 
pseudintermedius. 
The prevalence of agr groups in our clinical isolates is very different to that described 
by Little et al. (Little et al., 2019), with agrI being the unique group found in our collection, 
while any of the strains were assigned to one of the other three (agr II, III and IV). Following 
the suggestions of the author, in this contest, it is not possible to correlate the ability to produce 
biofilm with the corresponding agr group. Little et al. (2019) stated that strains harboring agrI 
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were more prone to produce biofilm and to be MDR. Our findings indicate a major ability for 
MDR bacteria to be strong biofilm producers. 
Among the virulence determinants analyzed in this study, only the prevalence of specific 
enterotoxin seC was found statistically significant between MDR and not-MDR strains (p-
value: 0.016). The prevalence of individual genes was similar to the literature (Futagawa-Saito 
et al., 2004; Yoon et al., 2010). 
 
Supplementary Materials: The following are available online at 
www.mdpi.com/xxx/s1 Table S1: Phenotypic and genetic determination of biofilm-forming 
ability. 
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Appendix A: Supplementary materials 
Supplementary Table 1  
Phenotypic and genetic determination of biofilm-forming ability 
 
non MDR strains MDR strains 
ID PCR icaA/icaD MtP ID PCR icaA/icaD MtP 
3 +/+ Weak 4 +/+ Moderate 
6A +/+ Weak 12 +/+ Strong 
7B1 +/+ Moderate 14 +/+ Strong 
8 +/+ Moderate 27 +/+ Weak 
10A +/+ Weak 28A +/+ Strong 
11B +/+ Weak 28B +/+ Strong 
13 +/+ Weak 238 +/+ Moderate 
16 +/+ Moderate 34 +/+ Moderate 
18A +/+ Weak 35 +/+ Strong 
19A +/+ Moderate 36 +/+ Strong 
20 +/+ Weak 37 +/+ Strong 
23 +/+ Weak 39 +/+ Strong 
26A +/+ Absent 41 +/+ Strong 
30B +/+ Moderate 42 +/+ Strong 
31 -/- Moderate 45 +/+ Strong 
48 +/+ Weak 46 -/+ Strong 
51 +/+ Weak 54 +/+ Strong 
53 +/+ Weak 56 +/+ Strong 
55 +/+ Weak 58 +/+ Moderate 
59 +/+ Weak 60 +/+ Moderate 
61 +/+ Weak 62 +/+ Strong 
70 +/+ Absent 63 -/+ Moderate 
74 +/+ Weak 64 -/+ Strong 
79 +/+ Moderate 66 -/+ Moderate 
84 +/+ Moderate 67 +/+ Moderate 
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85 +/+ Weak 71 +/+ Moderate 
91 +/+ Moderate 72 -/+ Strong 
96 +/+ Absent 76 +/+ Moderate 
98 +/+ Strong 77 -/+ Moderate 
234 +/+ Weak 78 -/+ Moderate 
502 +/+ Absent 81 -/+ Moderate 
   
82 +/+ Moderate 
   
87 -/+ Moderate 
   
89 -/+ Moderate 
   
93 +/+ Weak 
   
94 -/- Strong 
   
99 -/+ Strong 
   
102 -/+ Moderate 
   
104 -/+ Moderate 
   
105 +/+ Moderate 
   
107 +/+ Moderate 
   
117 +/+ Strong 
 
 
  
Chapter four 
 
 
108 
 
 
 
 
 
 
 
 
 
Chapter 4 
  
Chapter four 
 
 
109 
In vitro antibacterial activity of biological-derived silver nanoparticles: preliminary data 
 
Gabriele Meroni 1,2,*, Joel F. Soares Filipe1, Piera A. Martino 1 
 
1Department of Veterinary Medicine, Università degli Studi di Milano, Lodi, 26900, 
Italy 
2Department of Biomedical Sciences for Health, Università degli Studi di Milano, 
Milano, 20133, Italy 
*Correspondence: gabriele.meroni@unimi.it; Tel.: +39 0250315326 
 
 
 
 
 
 
 
 
 
 
 
Article submitted to Veterinary Sciences, Special Issue: Italian Society of the Veterinary 
Sciences SISVet 2019 
 
Chapter four 
 
 
110 
Abstract 
Silver nanoparticles (AgNPs) are promising alternatives to antibiotics. The aims of this 
study were the production of AgNPs using two biological methods and the determination of 
their antibacterial activity against P. aeruginosa and S. pseudintermedius. 
AgNPs were biosynthesized from an infusion of Curcuma longa and the culture 
supernatant of E. coli. Characterization was achieved by ultraviolet-visible spectroscopy and 
by Transmission Electron Microscopy (TEM). The antibacterial properties of NPs from C. 
longa (ClAgNPs) and E. coli (EcAgNPs), alone and in combination with carbenicillin and 
ampicillin, were investigated through the Kirby-Bauer disk diffusion assay and the minimum 
inhibitory concentration (MIC). 
Dimensions of NPs ranged from 11.107±2.705 nm (ClAgNPs) to 27.282±2.68 nm 
(EcAgNPs). Kirby-Bauer and MIC assays showed great antibacterial abilities for both NPs 
alone and in combination with antibiotics. EcAgNPs alone showed the most powerful 
antibacterial activities, resulting in MIC values ranging from 0.438±0.18 µM (P. aeruginosa) to 
3.75±3.65 µM (S. pseudintermedius) compared to those of ClAgNPs: 71.8±0 µM (P. 
aeruginosa) and 143.7±0 µM (S. pseudintermedius). The antibiofilm abilities were strain 
dependent but no statistical differences were found between the two NPs. 
These results suggest the antibacterial potential of AgNPs for the treatment of infectious 
diseases. 
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Introduction 
The introduction of nanoscale materials in the health industry is an emerging area of 
nanotechnology. In Europe, nanomaterials are defined as “natural, incidental or manufactured 
material containing particles, in an unbound state or as an aggregate or as an agglomerate and 
where, for 50 % or more of the particles in the number size distribution, one or more external 
dimensions is in the size range 1 nm -100 nm”(Commision, 2011). 
The unique characteristics of silver nanoparticles are due to their surface-to-volume 
ratio that considerably changes physical, chemical and biological properties; for these reasons 
the nanoparticles have been used for various purposes (Sharma et al., 2009) from textiles, 
keyboards, wound dressings, and biomedical devices (Sondi and Salopek-Sondi, 2004; Li et 
al., 2010). Size, shape, and surface coatings of nanoparticles are important characteristics that 
directly determine their biocidal activities (Zhang et al., 2016). Smaller particles have a larger 
surface to volume ratio and, therefore, display greater toxic potential. A recent study has found 
that the biological properties of AgNPs strictly depend on the different surface charges of their 
coatings, which can affect the physical interaction of AgNPs with microorganisms (Powers et 
al., 2011). 
Many methods have been used for the synthesis of silver nanoparticles, and nowadays 
are categorized as: a) chemical methods; b) physical methods and c) biological methods. 
In the chemical methods three main components, such as metal precursors, reducing 
agents, and stabilizing/capping agents are usually employed to produce metal nanoparticles. 
The physical approaches use direct interaction of laser or high voltage gate with raw metal, 
resulting in immediate nanoparticles release. To overcome the use of hazardous chemicals and 
the high energy consumption required by previous described procedures, biological methods 
have emerged as viable alternatives. The synthesis of AgNPs using green, cost-effective, and 
biocompatible methods can be achieved by bacteria (Kalimuthu et al., 2008; Kalishwaralal et 
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al., 2010), fungi (Birla et al., 2013), and plant extracts (Shameli et al., 2012; Gurunathan, 2015; 
Das et al., 2017). 
Biological methods offer numerous advantages compared to both chemical and physical 
ones: a) proteins and secondary metabolites are released by living organisms in the synthesis 
process; b) elimination of steps to prevent particles aggregation; c) eco-friendly and pollution-
free characteristics of biological molecules are used (Zhang et al., 2016). 
Silver (as silver ion) has been used as an antibacterial agent for centuries until the 
discovery of modern antibiotics. Today, the global spread of bacteria resistant to the most 
common antibiotics redirects the scientific research to alternative strategies able to fight also 
against multi-drug resistant (MDR) bacteria. Silver nanoparticles (AgNPs) have become a 
target for researchers due to their antimicrobial efficacy against bacteria, fungi, and viruses. In 
literature, the antibacterial properties of AgNPs against S. aureus, E. coli, P. aeruginosa and S. 
typhi are described by different authors (Liu et al., 2007; Sharma et al., 2009; Dakal et al., 
2016; Das et al., 2017). The antibacterial actions exerted by AgNPs are linked to: a) adhesion 
to cell wall, b) penetration and damaging of cytoplasmatic organelles; c) induction of oxidative 
stress via reactive oxygen species (ROS) production; d) modulation of signal transduction 
pathways (e.g. stress response pathway) (Quinteros et al., 2016). 
The specific aims of this study are: a) the set-up and optimization of protocols for the 
synthesis of silver nanoparticles using two biological methods and b) the analysis of their 
antibacterial and anti-biofilm properties against P. aeruginosa and S. pseudintermedius strains 
isolated from animals. 
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Materials and Methods 
Bacterial strains and culture conditions 
The bacterial strains used to study the antibacterial ability of AgNPs were randomly 
chosen from the bacterial collection of the Microbiology Laboratory of the Department of 
Veterinary Medicine of Università degli Studi di Milano. Ten strains of P. aeruginosa were 
isolated from eyes lavages of Chameleons (Furcifer pardalis); sheep blood agar and Cetrimide 
agar (Oxoid, Italy) were used to isolate and verify bacterial isolates belonging to Pseudomonas 
aeruginosa species. Ten Multi Drug Resistant (MDR) S. pseudintermedius strains were isolated 
from canine pyoderma and characterized phenotypically and genetically using, respectively, 
Mannitol Salt Agar (Microbiol, Italy) and the amplification of thermonuclease (nuc) gene as 
reported previously (Sasaki et al., 2010). The antibiotic-resistance profiles of each strain were 
assessed before this study with the Kirby-Bauer disk diffusion method; all the isolates were 
tested for amoxicillin + clavulanic acid (30 µg), amoxicillin (10 µg), cephalexin (30 µg), 
cefovecin (30 µg), ceftiofur (30 µg), ceftriaxone (30 µg), clindamycin (10 µg), lincomycin + 
spectinomycin (15 µg), doxycycline (30 µg), enrofloxacin (5 µg), marbofloxacin (5 µg), 
pradofloxacin (5 µg), amikacin (30 µg), gentamicin (30 µg), neomycin (30 µg), tobramycin (30 
µg), kanamycin (30 µg), rifampicin (30 µg), azithromycin (15 µg), erythromycin (30 µg). P. 
aeruginosa strains were also tested for carbenicillin (100 µg). All the strains were stored in 25% 
glycerol (Carlo Erba, Italy) at -20°C until use. However, before use, samples were thawed at 
room temperature and 10 μL were plated on Tryptic Soy Agar + 1% sheep blood (Microbiol, 
Italy) and incubated aerobically at 37°C for 24 h. Three or four isolated colonies were picked 
up and used to assess the antibacterial activity of silver nanoparticles. 
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Biosynthesis of AgNPs using Curcuma longa extract 
Preparation of C. longa extract 
The C. longa powder was kindly provided by Dr. G. Graziani (Farmacia Graziani, Italy). 
The production of C. longa extract was assessed using a protocol found in literature (Shameli 
et al., 2010) with some modifications. Briefly, after dissolving 0.1 g of Curcuma powder in 20 
mL of double distilled sterile water (ddH2O) the solution was stirred for 4 h at room temperature 
in dark conditions and filtered (Whatman® Grade 42, Ashless Filter Paper, USA) to remove 
debris. This solution was used to synthesize the nanoparticles. 
Synthesis and purification of silver nanoparticles 
Forty millilitres of 1% AgNO3 (Carlo Erba, Italy) were added to the fresh Curcuma 
extract and mixed (at 200 rpm) for 24 h in the dark (to avoid photochemical reactions) and at 
room temperature. The reduction of Ag+ to Ag0 was monitored by checking the change in colour 
of the solution: from a clear yellow to a progressive brown as found in the literature (Shameli 
et al., 2010; Gurunathan et al., 2014; Das et al., 2017). To remove Ag+, the solution was 
centrifuged at 4000 rpm for 20 minutes (Sigma 4-16KS); the supernatant was discarded and 
replaced with the same volume of sterile ddH2O. This step was repeated three times. The 
purified nanoparticles were stored at room temperature in dark conditions and sonicated (30 
kHz; SONICS Vibra cell), immediately before the assays, three times for 15 sec on and 45 sec 
off. The nanoparticles derived from C. longa synthesis were referred to as 
ClAgNPs.Biosynthesis of AgNPs using a cell-free extract of E. coli 
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Biosynthesis of AgNPs using a cell-free extract of E. coli 
Preparation of cell-free extract 
The bacterial strain E. coli ATCC® 25922 was used to synthesize silver nanoparticles. 
For the preparation of cell-free extract, the same conditions described by Kushawa et al (2015) 
were used (Kushwaha et al., 2015). Briefly, E. coli ATCC® 25922 was cultured in Mueller-
Hinton broth (Oxoid, Italy) and incubated aerobically at 37°C until reaching the logarithmic 
phase of growth (assessed by spectrophotometric reading at 550 nm). The biomass was removed 
from the supernatant by centrifugation at 4000 rpm for 20 minutes (Sigma 4-16KS); the liquid 
phase was filtered (0.22 µm syringe filter, Minisart® Sartorius, USA) to obtain the cell-free 
supernatant. To be sure about the absence of any residual bacteria in the supernatant, 10 µL 
were plated on Plate Count Agar (PCA, Condalab, Spain) and incubated aerobically at 37°C for 
24 h 
Synthesis and purification of bacterial silver nanoparticles 
Synthesis of AgNPs was carried out according to a method described previously 
(Gurunathan et al., 2009; Kushwaha et al., 2015). A 1% AgNO3 (Carlo Erba, Italy) solution 
was added to the cell-free extract and incubated by shaking (200 rpm) for 24 h in a dark 
environment at 37°C. The synthesized nanoparticles were centrifuged at 4000 rpm for 20 
minutes (Sigma 4-16KS) to remove the Ag+, and resuspended in ddH2O. This step was 
repeated three times. The nanoparticles derived from E. coli were referred to as EcAgNPs. 
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Characterization of AgNPs 
The characterization of purified nanoparticles was carried out using two of the most 
used methods reported by different authors (Gurunathan et al., 2009, 2014; Sharma et al., 2009; 
Saeb et al., 2014; Das et al., 2017). 
Ultraviolet-visible spectroscopy (UV-vis) 
Bio-reduction of Ag+ to Ag0 was monitored by measuring the absorption spectra (UV-
vis) with a spectrophotometer (SpectraMax 340 PC) collecting spectra over a range of 310 to 
770 nm (with an optical path length of 50 nm). Readings were recorded twice within 15 minutes. 
Transmission Electron Microscopy (TEM) 
Size analysis of colloidal silver was characterized by EFTEM Leo 912ab (Zeiss) at a 
voltage of 100 kV. The samples were briefly sonicated (30 kHz, 15 sec on and 45 sec off) and 
immediately a drop of the aqueous suspension of AgNPs was mounted on a carbon grid, which 
was placed on a filter paper to absorb the excess of solvent. The morphological analysis (particle 
diameter and size distribution) was calculated with Java image tool software (ImageJ). 
Antimicrobial properties 
Kirby–Bauer disk diffusion assay 
The antimicrobial activity of both ClAgNPs and EcAgNPs was tested against the 10 P. 
aeruginosa and 10 S. pseudintermedius strains and compared with antibiotics (carbenicillin and 
ampicillin, alone and in synergistic combination with silver nanoparticles) using the agar disk 
diffusion assay. Carbenicillin (Liofilchem, 100 µg) was used against P. aeruginosa and 
ampicillin (Oxoid, 10 µg) against S. pseudintermedius. Briefly, after plating each strain on a 
sterile Mueller-Hinton agar plate (Oxoid, Italy), antibiotics and virgin discs were placed on the 
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plates. In detail: two sterile discs were loaded with 20 𝜇L of silver nanoparticles, two discs with 
antibiotics and two discs with antibiotic supplemented with 20 𝜇L of silver nanoparticles, one 
disc was used as a negative control. All experiments were done in aseptic conditions in a 
laminar airflow cabinet and two replicates were done for each strain. The plates were incubated 
aerobically at 37°C for 24 h. Zones of inhibition for AgNPs, antibiotics, and antibiotics + 
nanoparticles were measured and expressed in millimetres (zone of inhibition ± SD). 
MIC 
The minimum inhibitory concentration (MIC) was determined using the microdilution 
assay according to the Clinical and Laboratory Standards Institute (CLSI) guidelines (CLSI, 
2017). Briefly, all the strains were grown on Brain Heart Infusion agar (BHI, Scharlau) and 
three or four colonies were suspended in fresh sterile saline solution to reach an initial 
concentration of 1.5 x 108 CFU/mL. One hundred microliters of the 1:100 diluted cell 
suspensions were dispensed into each well of a 96-well microtiter plate. The 10 strains of P. 
aeruginosa were exposed to twofold dilution series of NPs alone and in synergistic combination 
(1:1 ratio) with carbenicillin. The same was done for S. pseudintermedius strains except for 
ampicillin instead of carbenicillin. To rule out that the antibacterial activity may be exerted by 
AgNO3 instead of AgNPs, MIC for AgNO3 was also performed (data not shown). 
After incubation for 24 h at 37 °C, the MICs were determined as the lowest dilution of 
nanoparticles able to inhibit visible bacterial growth. 
Antibiofilm properties 
Screening for the biofilm-forming ability 
In a preliminary study (Figure S1), the biofilm-forming ability of the P. aeruginosa and 
S. pseudintermedius strains was studied using a microtiter plate assay (MtP) (Stepanovic et al., 
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2000; Stephanovic et al., 2007). As a negative control, TSB + 1% glucose (TSBg) without 
bacteria was used. Each strain was tested in triplicate on three independent plates. Briefly, fresh 
overnight subcultures of the strains were 1:100 fold diluted in TSBg and 200 μL were plated. 
After 24 h at 37 °C, the supernatant was gently removed and the biofilm was washed with sterile 
phosphate-buffered saline (PBS), fixed with methanol and stained with 2% crystal violet. The 
absorbance (550 nm) of negative controls was used to set the optical density cut-off (ODc) as 
three standard deviations above the mean OD of the negative controls. Strains were classified 
as follows: non-adherent OD≤ODc; weakly adherent ODc<OD 97 ≤2 × ODc; moderately 
adherent ODc<OD ≤4 × ODc; strongly adherent OD> 4 × ODc. Only the biofilm-producer 
strains were used to study the anti-biofilm properties of silver nanoparticles 
Interaction between AgNPs and mature biofilm 
To determine the ability of both ClAgNPs and EcAgNPs to disrupt mature biofilm, an 
MtP assay using a volume of 190 μL of bacteria culture (after 1:100-fold final dilution), and 10 
μL of AgNPs was carried out. Non-treated bacteria (NT) group was used to make a comparison 
with treated bacteria. 
Using the above-described method (Stephanovic et al., 2007), biofilm was grown at 
37°C for 24 h, then 10 μL of nanoparticles were added and the plates were further incubated 
for 24 hours. The disruptive ability of nanoparticles was determined by staining the biofilm 
biomass with crystal violet and measuring the absorbance at 550 nm (Labsystem Multiscan 
Plus). Each experiment was replicated three times per strain and three independent plates were 
used. 
Statistical analysis  
The statistical analysis, together with the graphical representation, were performed with 
GraphPad Prism v6 (GraphPad Software®, La Jolla California, USA). The results are presented 
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as follows: means ± SD for disc diffusion assay; µM ± SD for MIC; OD ± SD for anti-biofilm 
activity. All data were tested for normality and analysed using Student’s t-test and a p-value 
less than 0.05 was considered statistically significant. 
Results 
Synthesis of AgNPs 
The change in colour (darkish-brown) of the silver solutions was used to monitor the 
bio-reduction of silver ions to silver nanoparticles (Fig. 1). The intensity of brown increased 
during time as found in the literature. C. longa solution showed a more explicit darkish-brown 
appearance after the period of incubation (Fig. 1A) suggesting a stronger synthesis of NPs. On 
the contrary, the supernatant of E. coli turned immediately from yellow to yellow-white 
appearance without showing a brown aspect (Fig. 1B). The confirmation of NPs synthesis and 
stability was monitored by UV-vis spectroscopy, while the morphological analysis was 
performed with TEM. 
 
Figure 1. Biosynthesis of silver nanoparticles. 
Plant-mediated method (a) after dissolving C. longa powder in ddH2O the solution was 
filtered to remove the majorities of vegetal debris, finally, silver nitrate was added and the 
change in colour was monitored. Bacterial supernatant method (b). After growing E. coli 
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ATCC® 25922 in Mueller-Hinton broth, the supernatant was collected and silver nitrate was 
added to induce nanoparticle synthesis. 
UV-vis spectroscopy 
UV-vis spectroscopy is considered one of the most important tools for the evaluation of NPs 
synthesis (Gurunathan et al., 2014). The absorption spectra of the AgNPs are shown in Fig. 2. 
ClAgNPs showed a clear absorption peak at around 440 nm, confirming the production of 
colloidal silver nanoparticles. On the other hand, EcAgNPs showed a logarithmic-like curve 
which not clearly shows a specific absorption peak and suggest any NPs formation. To exclude 
an instrumental bias, serial dilution of EcAgNPs were loaded in the spectrophotometer with the 
same results in term of peak’s absence. 
 
Figure 2 UV-vis spectroscopy of ClAgNPs and EcAgNPs. 
Size and morphology analysis of silver nanoparticles 
To understand the size of colloidal silver particles and provide more robust data about 
their morphology, TEM investigations were conducted with EFTEM Leo 912ab (Fig. 3 A-D) 
while morphological measurements were estimated with ImageJ software to build the frequency 
distribution of particle diameter (Fig. 3 C, E). It could be observed that NPs obtained with 
Curcuma showed a spherical symmetry and heterogeneous spatial dimensions ranging from 10 
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to 25 nm (11.1±2.75 nm). The presence of narrow particles was in accordance with the UV-vis 
results. Fig. 3A-B shows ClAgNPs enclosed in Curcuma extract.  
the analysis of E. coli supernatant showed nanoparticles enclosed in a matrix that 
connected each particle to the other (Fig. 3B, C). These particles seemed to have a spherical 
symmetry and diameter ranging from 15 nm to 35 nm (27.28±2.68 nm). Maybe, this particular 
spatial configuration was responsible for the lack of a unique 440 nm peak investigated with 
UV-vis. 
Overall, for both ClAgNPs and EcAgNPs the results were in accordance with the 
literature (Shameli et al., 2010; Zhang et al., 2016) confirming that biological methods for the 
synthesis of AgNPs produce nanoparticles lacking homogeneity. 
After the morphological analysis, the determination of the molar concentration of silver 
nanospheres was determined as reported in the literature (Liu et al., 2007; Kalishwaralal et al., 
2010) 
 
Figure 3 Morphological analysis by TEM. 
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(a,c) NPs derived from C. longa showed spherical symmetry and mean diameter of 11.1 
nm. (b,d) EcAgNPs showed a highly-branched symmetry and dimension of 27.28 nm in 
diameter 
Antibacterial activity 
Kirby – Bauer disk diffusion assay 
The potential synergistic effects of combining silver nanoparticles with antibiotics were 
evaluated with the disk diffusion assay (Fig. 4). All the P. aeruginosa and staphylococcal strains 
were, respectively, resistant to carbenicillin and ampicillin. The antibacterial activity of both 
ClAgNPs and EcAgNPs increased when in combination with antibiotics in all the tested strains 
showing significant differences (p<0.05) in comparison with silver nanoparticles alone (Fig. 4 
A-D). For P. aeruginosa strains (Fig. 4 A, C) ClAgNPs and EcAgNPs alone showed a mean 
inhibition halo of 9.5 and 14.4 mm respectively resulting in statistical differences when 
compared to carbenicillin+ClAgNPs (14 mm), and carbenicillin+EcAgNPs (17.45 mm). For S. 
pseudintermedius strains (Fig. 4 B, D) statistically differences were found between ClAgNPs 
and EcAgNPs alone (12.8 mm, and 16.4 mm, respectively), and in combination with ampicillin 
(19.61 mm, and 21.38 mm, respectively). The interpretation of Kirby-Bauer assay, using CLSI 
breakpoints, showed that all the staphylococcal strains were considered resistant to ampicillin 
even after the synergistic combination with NPs (resistance for ampicillin is < 29 mm), while 
P. aeruginosa strains were resistant against carbenicillin alone, but when NPs were added the 
strains were susceptible. 
The statistical differences between the two nanoparticles tested are shown in Fig. 5, 
giving reasons to hypothesize a better antibacterial ability of EcAgNPs, but only in 
staphylococcal strains. This result is in contrast with the literature in which Gram-negative 
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bacteria are reported as more susceptible to silver nanoparticles than Gram-positive depending 
on differences in their cell wall structure. 
 
Fig. 4. Disk Diffusion Assay.  
Effect of NPs used alone and in synergistic combination with carbenicillin against P. 
aeruginosa and ampicillin against S. pseudintermedius. Statistical analysis showed differences 
between inhibition halos of silver nanoparticles alone and those of silver in combination with 
carbenicillin (a,c) and ampicillin (b,d). Results are presented as mean±SD (*p value: 0,05-0,01; 
**p value: <0.01; ***p value: <0,001). 
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Fig. 5. Antibacterial ability of ClAgNPs and EcAgNPs  
T-student’s test revealed significant differences between ClAgNPs, and EcAgNPs in S. 
pseudintermedius strains (p-value ≤0.001).  
MIC 
MIC (Table 1 and Figure 6) of each tested strain was determined for both ClAgNPs, and 
EcAgNPs alone and in synergistic combination with carbenicillin (for P. aeruginosa) and 
ampicillin (for S. pseudintermedius). As found in Kirby-Bauer assay, P. aeruginosa and S. 
pseudintermedius were resistant to carbenicillin (512 µg/mL) and ampicillin (56±40.63 
µg/mL). The results of NPs showed that MIC were different between Gram-negative and Gram-
positive bacteria. When the antibiotics were adjuvated (1:1 ratio) with ClAgNPs and EcAgNPs, 
the MIC were significantly lower resulting in sensible profiles (according to CLSI breakpoints). 
For both Gram-positive and Gram-negative bacteria, significant differences were found 
comparing the same antibiotic adjuvated with ClAgNPs and EcAgNPs and showing a lower 
MIC (better antimicrobial activity) for nanoparticles synthesized from E. coli supernatant. 
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 P. aeruginosa S. pseudintermedius 
Atb (µg/mL) 512±0 56±40,63 
ClAgNPs (µM) 71,8±0 143,7±0 
Atb+ClAgNPs (µg/mL) 6,4±4,2 6,2±2,4 
EcAgNPs (µM) 0,438±0,18 3,75±3,65 
Atb+EcAgNPs (µg/mL) 0,48±0,37 0,5±0,27 
 
Table 1. Determination of MIC values for ClAgNPs and EcAgNPs alone and in 
combination with antibiotics. (Atb: antibiotic; carbenicillin 512-1 µg/mL for P. aeruginosa; 
ampicillin 256-0.5 µg/mL for S. pseudintermedius). 
 
Fig. 6. MIC of NPs in combination with ampicillin and carbenicillin. 
Statistical differences were found between the combination ampicillin+ClAgNPs and 
the same antibiotic adjuvated with EcAgNPs (p-value= 0.002). Similarly, carbenicillin showed 
lower MIC when in synergistic combination with EcAgNPs instead of ClAgNPs (p-value= 
0.0023). 
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Antibiofilm properties 
The formation of biofilm is a highly coordinated process during which bacteria adhere 
to each other and to biotic/abiotic surfaces, resulting in the formation of a complex community 
enclosed in a self-produced extracellular matrix. 
Following preliminary assays for the screening of biofilm-forming ability 
(Supplementary figure 1), 8 and 7 strains among, respectively P. aeruginosa and S. 
pseudintermedius, were selected for their biofilm-forming ability. 
These strains were grown for 24 h in microtiter plates and then exposed to ClAgNPs 
and EcAgNPs following a 1:20 dilution. The results (Fig. 7) confirm the anti-biofilm ability of 
silver nanoparticles but only for P. aeruginosa strains the inhibition was statistically significant 
(p<0.05) between the non-treated group and both nanoparticles. For staphylococcal strains, no 
differences were found between NT and both nanoparticles, but a negative trend could be 
observed between NT and ClAgNPs. 
 
Fig. 7. Anti-biofilm properties of NPs 
Statistical differences were found only among Pseudomonas strains (*p value: 0,05-
0,01; **p value: <0.01; ***p value: <0,001). 
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Discussion 
In this study, the antibacterial and anti-biofilm properties of silver nanoparticles, 
synthesized using two biological methods were determined using different in vitro assays 
against P. aeruginosa and MDR S. pseudintermedius strains isolated from clinical patients from 
the veterinary teaching hospital of the University of Milan. To achieve these objectives silver 
nanoparticles were synthesized using a) Curcuma longa powder, and b) the supernatant of E. 
coli ATCC® 25922; then their characterization was performed using UV-vis spectroscopy and 
TEM analysis. Finally, the disk diffusion test, the determination of the MIC values and the time-
killing assay demonstrated the high bactericidal ability of NPs against both Pseudomonas and 
Staphylococcus. The ability to disrupt mature biofilm was determined using a microtiter assay. 
It is well known that classical chemical methods produce more homogeneous and long-
term stable particles but contrary to biological methods, a lot of potentially hazardous chemicals 
are used to synthesize and stabilize silver nanoparticles (e.g. sodium borohydride and sodium 
citrate) (Zhang et al., 2011, 2016; Wei et al., 2016). Molecules from living organisms (e.g. 
proteins and amino acids) or extract from plants (e.g. phenols and aldehydes) act like reducing 
and capping agents, making the biological methods more eco-friendly and less expensive, but 
producing more heterogeneous particles (Sharma et al., 2009). The oxidation of aldehyde 
(naturally present in Curcuma root) to carboxylic groups allows to reduce Ag+ and control the 
shape of spherical nanoparticles (Shameli et al., 2010). 
The proteins expressed during the bacterial life (e.g. nitrate reductase) actively reduce 
silver ions to silver nanoparticles, changes in pH and temperature affect this reaction with the 
final effect of producing nanoparticles of different dimensions (Gurunathan et al., 2009). 
In this study the nanoparticles produced by Curcuma powder and E. coli shown 
heterogeneous dimensions as observed on previous studies (Gurunathan et al., 2009; Shameli 
et al., 2010; Kushwaha et al., 2015; Das et al., 2017). However, particles dimensions were 
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different (11.107±2.705 nm for C. longa and 27.282±2.68 nm for E. coli) from those observed 
in the literature in which NPs ranged from 6.3-2.64 nm (Shameli et al., 2010) to 50 nm 
(Gurunathan et al., 2009). One possible explanation could be the differences in terms of raw 
material use (e.g. quality of Curcuma powder) and the bacterial strain used. 
The disk diffusion assay demonstrated the ability of NPs (alone or in combination with 
antibiotics) to kill more easily antibiotic-resistant bacteria. In particular, statistical differences 
were found in S. pseudintermedius between nanoparticles from E. coli and Curcuma underlying 
the major effect of bacterial-derived nanoparticles. These results allow us hypothesize that 
nanoparticles are broad-spectrum agents as described in literature (Lara et al., 2010). It has to 
be noted that, in the specific case of S. pseudintermedius, the measurement of the diameter in 
the Kirby-Bauer assay after NPs addition gives a resistant profile of these bacteria. The MIC 
values are in agreement with the literature in which NPs are reported as being more active 
against Gram-negative bacteria (Das et al., 2017). From the comparison of ClAgNPs and 
EcAgNPs between S. pseudintermedius and P. aeruginosa, only EcAgNPs were found 
statistical different in S. pseudintermedius, these results seem to be in contrast with MIC values, 
but could be explained by the presence of E.coli proteins residues (used for the synthesis of 
EcAgNPs) present on the surface of NPs that could interfere with the staphylococcal growth in 
a similar way of chemical synthesis of NPs (Shahverdi et al., 2007). It is well documented that 
the quorum-sensing pathways, devoted to bacterial growth, communication and expression of 
virulence factors, are linked to the expression of species-specific peptides, experimentally 
peptides derived from Gram-negative bacteria are able to inhibit the growth or expression of 
specific proteins of Gram-positive (Kong et al., 2006). 
One of the most studied bacterial virulence factors is the ability to produce biofilm 
through the quorum-sensing communication system. Biofilm development is related to 
environmental signals and communication systems, that reflect on specific gene expression 
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(Hall and Mah, 2017). Nanoparticles from both Curcuma and bacterial synthesis are able to 
destroy the mature biofilm of Pseudomonas. The reason for this higher activity could be the 
adsorption of biomolecules on the surface of bacteria, due to electrostatic attraction 
(Kalishwaralal et al., 2010).  
The synthesized AgNPs showed antibacterial activity alone and in combination with 
common antibiotics, suggesting a potential use as alternative therapies in case of Multi Drug 
Resistant-derived infections. Their ability to destroy mature biofilm has to be properly studied 
in terms of localization and elaboration of other nanoparticles-based approaches 
Conclusions 
Two different biological methods are used in this study to synthesize silver 
nanoparticles: one via C. longa powder, the second using the supernatant of E. coli ATCC® 
25922 strain. UV-vis spectroscopy and transmission electron microscopy were used to analyze 
the neo-synthesized nanoparticles, the results confirmed the ability of natural products (present 
in Curcuma root) and bacterial proteins to reduce and cap silver ions generating nanoparticles 
very small in size.  
The antibacterial abilities of these nanoparticles were tested against P. aeruginosa and 
MDR staphylococcal strains through commonly used assays. It was shown that AgNPs are 
particularly effective against Gram-negative bacteria even in small concentrations. The mature 
biofilm (produced by both Gram-positive and Gram-negative bacteria) can be though as a 
potential target for silver nanoparticles-based therapies. 
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Appendix A: Supplementary materials 
Supplementary figure 1 
Biofilm forming ability of Pseudomonas and Staphylococcus strains.  
 
Optical densities of all the strains as measured following the method previously 
described (Stepanović et al., 2007). After MtP assay, among the 10 Pseudomonas strains, 8 
were considered strongly biofilm producers. Among the 10 S. pseudintermedius strains 4 
resulted in non-biofilm-producers, 2 weakly producers and 4 strongly producers. 
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General discussion and conclusions 
Canine pyoderma is the result of different associated factors: the host, the pathogen and 
the surrounding environment. After the introduction of more discriminative diagnostic 
techniques, the reclassification of S. intermedius finally identified in S. pseudintermedius the 
most frequently pyoderma-associated pathogen. 
This thesis focused on four areas associated with S. pseudintermedius, in order to: i) 
better describe the molecular characterization of this pathogen, ii) evaluate the emerging 
problem of antibiotic-resistance through a comparison between two different veterinary 
teaching hospitals, iii) analyze the zoonotic potential of some strains related with their ability 
to produce biofilm and to resist to antibiotic treatment, and iv) find a valid alternative to 
antibiotic-based therapies using silver ions as precursor for nanoparticles. 
Our survey put the basis for further investigations, one of the future plans consisting of 
the study of resistome and all resistance-associated genes. In fact, in literature, the OMICs-
based approaches are currently fast-growing research areas able to deeper investigate the origin 
and evolution of antibiotic-resistance. 
It is already known that the evolution of traditional antibiotics will be based on the 
attenuation of bacterial virulence using peptides or small interfering RNAs. S. pseudintermedius 
offers a large variety of possible molecular targets first of all the 18 Cell Wall Anchored proteins 
without which the adhesion will not take place, avoiding the downstream penetration and 
multiplication bacterial phases. 
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